Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	centrosome	PDE4D RAB11A STOX1 SPICE1 CCDC66 UBN1 MIB1 NLRC5 DYRK3 CEP290 OBSL1 CEP192 XRCC2 NCKAP5L DZANK1 FRY AKAP9 LRRCC1 CDK5RAP2 ESPL1	1.18e-04	770	212	20	GO:0005813
GeneOntologyCellularComponent	pericentriolar material	DYRK3 CEP192 AKAP9 CDK5RAP2	1.74e-04	28	212	4	GO:0000242
MousePheno	renal glomerular protein deposits	ABCA1 TLR8 FEN1 C4A C4B TNS2	1.54e-05	42	181	6	MP:0020518
Domain	SPEC	SPTAN1 EVPL DST UTRN SESTD1	2.57e-05	32	208	5	SM00150
Domain	Spectrin/alpha-actinin	SPTAN1 EVPL DST UTRN SESTD1	2.57e-05	32	208	5	IPR018159
Domain	IG_FLMN	FLNC TRIM2 TRIM3	1.54e-04	10	208	3	SM00557
Domain	Filamin	FLNC TRIM2 TRIM3	2.10e-04	11	208	3	PF00630
Domain	FILAMIN_REPEAT	FLNC TRIM2 TRIM3	2.10e-04	11	208	3	PS50194
Domain	Filamin/ABP280_rpt	FLNC TRIM2 TRIM3	2.10e-04	11	208	3	IPR001298
Domain	Filamin/ABP280_repeat-like	FLNC TRIM2 TRIM3	2.10e-04	11	208	3	IPR017868
Domain	Spectrin_repeat	SPTAN1 EVPL DST UTRN	2.85e-04	29	208	4	IPR002017
Domain	EF-hand_like	PLCL2 PLCB1 PLCL1	5.61e-04	15	208	3	PF09279
Domain	PI-PLC-Y	PLCL2 PLCB1 PLCL1	5.61e-04	15	208	3	PF00387
Domain	PLCYc	PLCL2 PLCB1 PLCL1	5.61e-04	15	208	3	SM00149
Domain	PLipase_C_Pinositol-sp_Y	PLCL2 PLCB1 PLCL1	5.61e-04	15	208	3	IPR001711
Domain	PIPLC_Y_DOMAIN	PLCL2 PLCB1 PLCL1	5.61e-04	15	208	3	PS50008
Domain	PI-PLC_fam	PLCL2 PLCB1 PLCL1	5.61e-04	15	208	3	IPR001192
Domain	PLC_EF-hand-like	PLCL2 PLCB1 PLCL1	5.61e-04	15	208	3	IPR015359
Domain	Tensin_PTB	TNS3 TNS2	7.30e-04	4	208	2	IPR033929
Domain	BROMODOMAIN_1	BRWD1 BAZ1A BRD7 SMARCA2	7.40e-04	37	208	4	PS00633
Domain	Bromodomain	BRWD1 BAZ1A BRD7 SMARCA2	8.20e-04	38	208	4	PF00439
Domain	-	KCTD9 TLR8 SLIT2 NOD1 LRRTM4 NLRC5 ADGRA3 ZYG11A MXRA5 LRRC40 LRRCC1	9.80e-04	321	208	11	3.80.10.10
Domain	Integrin_alpha-2	ITGA2B ITGAV ITGA11	9.82e-04	18	208	3	IPR013649
Domain	CTCK_1	SLIT2 VWF MUC19	9.82e-04	18	208	3	PS01185
Domain	PI-PLC-X	PLCL2 PLCB1 PLCL1	9.82e-04	18	208	3	PF00388
Domain	INTEGRIN_ALPHA	ITGA2B ITGAV ITGA11	9.82e-04	18	208	3	PS00242
Domain	PLCXc	PLCL2 PLCB1 PLCL1	9.82e-04	18	208	3	SM00148
Domain	Integrin_alpha2	ITGA2B ITGAV ITGA11	9.82e-04	18	208	3	PF08441
Domain	Integrin_alpha	ITGA2B ITGAV ITGA11	9.82e-04	18	208	3	IPR000413
Domain	BROMODOMAIN_2	BRWD1 BAZ1A BRD7 SMARCA2	1.10e-03	41	208	4	PS50014
Domain	Int_alpha	ITGA2B ITGAV ITGA11	1.16e-03	19	208	3	SM00191
Domain	Int_alpha_beta-p	ITGA2B ITGAV ITGA11	1.16e-03	19	208	3	IPR013519
Domain	PIPLC_X_DOMAIN	PLCL2 PLCB1 PLCL1	1.16e-03	19	208	3	PS50007
Domain	PLipase_C_PInositol-sp_X_dom	PLCL2 PLCB1 PLCL1	1.16e-03	19	208	3	IPR000909
Domain	L_dom-like	KCTD9 TLR8 SLIT2 NOD1 LRRTM4 NLRC5 ADGRA3 ZYG11A MXRA5 LRRC40 LRRCC1	1.17e-03	328	208	11	IPR032675
Domain	Bromodomain	BRWD1 BAZ1A BRD7 SMARCA2	1.20e-03	42	208	4	IPR001487
Domain	BROMO	BRWD1 BAZ1A BRD7 SMARCA2	1.20e-03	42	208	4	SM00297
Domain	-	BRWD1 BAZ1A BRD7 SMARCA2	1.20e-03	42	208	4	1.20.920.10
Domain	Anaphylatoxin_comp_syst	C4A C4B	1.21e-03	5	208	2	IPR018081
Domain	Anaphylatoxn_comp_syst_dom	C4A C4B	1.21e-03	5	208	2	IPR001840
Domain	P-loop_NTPase	KIF21B MAGI1 RAB11B ABCA1 ERCC2 SETX THNSL1 CENPE ABCA13 RAB11A NWD2 NOD1 NAV2 NLRC5 ABCG2 KIF27 CHD8 ZNFX1 XRCC2 SMARCA2	1.30e-03	848	208	20	IPR027417
Domain	t-SNARE	STX5 GARIN5B CDK5RAP2 STX6	1.31e-03	43	208	4	IPR010989
Pubmed	A human MAP kinase interactome.	MAGI1 SETX SPTAN1 EVPL SYNPO STAT1 DST SYNJ2 TNRC6A PLCB1 NAV2 C4A MAP3K7 COPS5 HSPA5 FLNC VWF TCF20 ABI3BP CEP290 CHD8 NCKAP5L ZNF106 ATF6 USF3 AKAP13 MBD5 EPAS1	7.54e-19	486	218	28	20936779
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KIF21B KDM3A SETX SYNPO RNF40 CEMIP2 DST NRXN2 SYNJ2 MIB1 TNRC6A PLCB1 NAV2 ANKS1A SUN1 CHD8 CDK5RAP2 PCNX1 ESPL1 ZMYM4	1.88e-10	529	218	20	14621295
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KIF21B MAGI1 KCTD9 NES CENPE SPTAN1 SYNPO GIT2 SPICE1 DST TMEM259 PLCB1 PLCL1 ANKS1A SESTD1 TCF20 ARHGEF12 CHD8 ZNFX1 TRIM3 DZANK1 FRY AKAP9 BRD7 CDK5RAP2 FRMPD3	4.85e-10	963	218	26	28671696
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	NES CENPE RNF40 CDKAL1 CEMIP2 STRIP2 SYNJ2 TNRC6A TNS3 ANKS1A TCF20 GOSR1 SUN1 CEP290 BAG2 NCKAP5L PAPOLG ZNF106 SETD2 KIN AKAP13 ESPL1	1.69e-09	733	218	22	34672954
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	KDM3A SRRM1 SETX BCORL1 SYNPO ACTL6A PRDM2 UBN1 FEN1 BRWD1 NPAT DEAF1 TCF20 POLA1 CHD8 SIN3A PAPOLG BAZ1A BRD7 ZMYM4	2.06e-09	608	218	20	36089195
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	ACACB SPTAN1 BCORL1 CDKAL1 TNRC6A TCF20 POLA1 OBSL1 LRRC40 ZNF106 MARK2 ESPL1	4.90e-08	242	218	12	34011540
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	SRRM1 ZC3H13 SPTAN1 RAB11A CDKAL1 CEMIP2 SPICE1 STX5 PMPCA MIB1 HSPA5 PUS7 PML NPAT SUN1 BAG2 ZDHHC5 OBSL1 LRRC40 CEP192 VARS2 NCKAP5L ATF6 AKAP9 DNAJC14 CDK5RAP2 AKAP13 MARK2 ESPL1	6.57e-08	1487	218	29	33957083
Pubmed	alphaII-Spectrin interacts with five groups of functionally important proteins in the nucleus.	ERCC2 ERCC4 SPTAN1 PML XRCC2 SMARCA2	6.58e-08	34	218	6	16889989
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	KDM3A SRRM1 ZC3H13 SPTAN1 PRDM2 SPICE1 UBN1 ANKS1A DEAF1 TCF20 SIN3A PAPOLG LIG1 ZNF106 SETD2 SMARCA2 MARK2 ESPL1 ZMYM4 CDH17	1.11e-07	774	218	20	15302935
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MAGI1 SRRM1 NES SETX SPTAN1 SPICE1 STX5 DST SYNJ2 NAV2 UTRN TNS3 PML ANKS1A TCF20 CEP192 NCKAP5L ZNF106 AKAP9 AKAP13 MARK2	1.38e-07	861	218	21	36931259
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	KDM3A SPTAN1 SYNPO RNF40 STAT1 EFEMP1 DST MIB1 UTRN ALDH5A1 COPS5 HSPA5 BRWD1 SESTD1 VWF CEP290 OBSL1 TTC27 ZNFX1 SEC31B ATF6 FRY DNAJC14 AKR1C3 LRRCC1 ZMYM4	1.66e-07	1285	218	26	35914814
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	SPTAN1 CEMIP2 SPICE1 PHKA1 PMPCA PTPRM PLCL2 MIB1 TNRC6A MAP3K7 UTRN HSPA5 TNS3 SUN1 CEP290 BAG2 ZDHHC5 TTC27 TNS2 CEP192 NCKAP5L AKAP9 CDK5RAP2	2.25e-07	1049	218	23	27880917
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	NES CDKAL1 DST COPS5 PUS7 TNS3 PML TCF20 POLA1 CHD8 RSBN1 LIG1 BAZ1A BRD7 SMARCA2	3.54e-07	472	218	15	38943005
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ERCC4 SETX ZC3H13 AKR1C1 STAT1 PRDM2 STX5 PLCL2 UTRN PML BRWD1 NPAT SESTD1 SUN1 APOB CEP192 CUBN KIN BAZ1A AKR1C3 CDK5RAP2 ESPL1 ZNF445	3.98e-07	1084	218	23	11544199
Pubmed	Tcf20 deficiency is associated with increased liver fibrogenesis and alterations in mitochondrial metabolism in mice and humans.	NES MMP12 TCF20 TIMP1	4.79e-07	11	218	4	37312667
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ERCC2 SPEG RNF40 ZDHHC8 DST UBN1 TULP4 TMEM259 NAV2 NLRC5 ULK4 ULK1 DENND5A FLNC ZDHHC5 CHD8 CEP192 GBA2 DNAJC14 PCNX1 AKAP13 MBD5 ESPL1	5.54e-07	1105	218	23	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SRRM1 ERCC2 GCDH ACTL6A CDKAL1 SLIT2 SCAPER TNRC6A PML BRWD1 FAT3 BAG2 OBSL1 TTC27 ECT2L CHD8 ZKSCAN2 SIN3A NCKAP5L RSBN1 SETD2 BRD7 SMARCA2	6.57e-07	1116	218	23	31753913
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	MAGI1 RAB11B SPAG1 SPTAN1 EVPL STAT1 CEMIP2 STX5 DST SYNJ2 NAV2 UTRN HSPA5 ZDHHC5 ARHGEF12 MARK2	6.61e-07	565	218	16	25468996
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ERCC4 SETX THNSL1 CEMIP2 EFEMP1 DST C4A C4B ULK1 DENND5A OBSL1 CHD8 ZNFX1 SIN3A NOM1 AKAP13 MARK2	8.76e-07	650	218	17	38777146
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	KDM3A SETX SYNPO RNF40 STAT1 STX5 UBN1 HSPA5 PML FLNC CHD8 PAPOLG ZNF106 ZMYM4	9.63e-07	444	218	14	34795231
Pubmed	TBC1D14 regulates autophagosome formation via Rab11- and ULK1-positive recycling endosomes.	RAB11B RAB11A ULK1	9.67e-07	4	218	3	22613832
Pubmed	Macrophage-derived complement component C4 can restore humoral immunity in C4-deficient mice.	STAT1 C4A C4B	9.67e-07	4	218	3	12421924
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	SETX CENPE ZC3H13 BCORL1 EVPL STOX1 PRDM2 DST UTRN HSPA5 CCDC170 MXRA5 POLA1 CEP290 MUC19 LRRC40 FRY AKAP13	1.08e-06	736	218	18	29676528
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	SRRM1 ERCC2 PHKA1 DST SCAPER ULK1 MAP3K7 UTRN COPS5 HSPA5 TNS3 AFF3 OBSL1 TNS2 CEP192 SIN3A AKAP9 CDK5RAP2 MARK2 ESPL1	1.39e-06	910	218	20	36736316
Pubmed	Human variation in alcohol response is influenced by variation in neuronal signaling genes.	PDE4D ERCC4 SYNPO AKR1C1 PTPRM ALDH5A1 VWF AKR1C3 CDK5RAP2	1.46e-06	171	218	9	20201926
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	DST NRXN2 SYNJ2 PLCL2 SCAPER ZNFX1 CDK5RAP2 MBD5	1.77e-06	130	218	8	12421765
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	MAGI1 ERCC2 BCORL1 GCDH SYNPO ACTL6A STAT1 UBN1 FEN1 MIB1 SCAPER POLA1 CEP290 AKAP9 CDK5RAP2 AKAP13 MBD5	1.93e-06	689	218	17	36543142
Pubmed	A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.	KCTD9 ABCA13 SPTAN1 PRDM2 DST HSPA5 POLA1 BAG2 ARHGEF12 CHD8 LRRCC1	2.04e-06	284	218	11	29459677
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SRRM1 RAB11B SETX ACACB RAB11A CEMIP2 STX5 DST TNRC6A MAP3K7 GOSR1 ZDHHC5 APOB CEP192 LIG1 KIN NOM1 CDK5RAP2	2.31e-06	777	218	18	35844135
Pubmed	The generation of thymus-independent germinal centers depends on CD40 but not on CD154, the T cell-derived CD40-ligand.	C4A C4B CD40	2.41e-06	5	218	3	16783845
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ACACB ITGAV CDKAL1 CEMIP2 STX5 DST PTPRM PLCB1 UTRN GOSR1 ZDHHC5 MARK2 STX6	2.98e-06	421	218	13	36976175
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	SRRM1 SETX SPTAN1 GSDME UBN1 FEN1 COPS5 HSPA5 KIF27 LRRC40 CHD8 SEC31B BRD7 SMARCA2 MARK2	4.68e-06	582	218	15	20467437
Pubmed	Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study.	ERCC2 ERCC4 XRCC2	4.79e-06	6	218	3	16284380
Pubmed	Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans.	ERCC2 ERCC4 LIG1	4.79e-06	6	218	3	18709642
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	MAGI1 ACACB SPTAN1 SPICE1 DST TNRC6A UTRN ANKS1A BAG2 CEP192 NCKAP5L AKAP9 MARK2	5.55e-06	446	218	13	24255178
Pubmed	DNA repair gene variants associated with benign breast disease in high cancer risk women.	ERCC2 ERCC4 XRCC2	8.35e-06	7	218	3	19124519
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	SETX TNRC6A PML ANKS1A CEP290 OBSL1 CHD8 SIN3A LIG1 BAZ1A NOM1 BRD7 ZMYM4	9.49e-06	469	218	13	27634302
Pubmed	Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.	KIF21B ARHGAP30 STAT1 CDKAL1 PMPCA FEN1 PLCL1 MUC19 IL20 CD40 FUT2	1.19e-05	342	218	11	23128233
Pubmed	Detection of genes regulated by Lmx1b during limb dorsalization.	MATN1 EFEMP1 AFF3 INSYN2B	1.21e-05	23	218	4	22417325
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	ERCC4 ACTL6A UBN1 PML TCF20 AFF3 ZNF106 KIN ZMYM4	1.22e-05	222	218	9	37071664
Pubmed	A protein interaction landscape of breast cancer.	SRRM1 ERCC2 SYNPO ACTL6A STX5 DST NAV2 ALDH5A1 COPS5 BAG2 XRCC2 ZNF106 NOM1 BRD7 SMARCA2	1.29e-05	634	218	15	34591612
Pubmed	Neurons under T Cell Attack Coordinate Phagocyte-Mediated Synaptic Stripping.	STAT1 C4A C4B	1.33e-05	8	218	3	30173917
Pubmed	Casein kinase 1δ functions at the centrosome and Golgi to promote ciliogenesis.	RAB11A CEP290 AKAP9	1.33e-05	8	218	3	24648492
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	PDE4D CENPE TMEM63B ACTL6A SPICE1 SYNJ2 MIB1 ABCG2 COPS5 RGPD5 TTC27 CEP192 ZNF106 KIN BRD7 SMARCA2 CDK5RAP2 MARK2 ESPL1 ZMYM4 ZNF124	1.39e-05	1155	218	21	20360068
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ACACB BCORL1 RNF40 PRDM2 DST TNRC6A UTRN NPAT TCF20 TTC27 CHD8 ZMYM4	1.49e-05	418	218	12	34709266
Pubmed	Interaction network of human early embryonic transcription factors.	ACACB BCORL1 ACTL6A PRDM2 ALDH5A1 TCF20 CHD8 BAZ1A BRD7 SMARCA2 ZMYM4	1.51e-05	351	218	11	38297188
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	SRRM1 ABCA1 SETX ACACB CEMIP2 LRRTM4 HSPA5 TNS3 DYRK3 APOB PCNX1 ZMYM4	1.56e-05	420	218	12	28065597
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TULP4 SCAPER PUS7 CEP290 ZDHHC5 VARS2 GBA2 SEMA4G SETD2 USF3 LRRCC1 ARHGAP28 MBD5	1.61e-05	493	218	13	15368895
Pubmed	DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma.	ERCC2 ERCC4 XRCC2 LIG1	1.71e-05	25	218	4	20150366
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	KIF21B ACACB CENPE SPEG ACTL6A NAV2 C4A C4B COPS5 BAG2 ZNF106 ZNF540 MARK2	1.75e-05	497	218	13	36774506
Pubmed	Suppressing UPR-dependent overactivation of FGFR3 signaling ameliorates SLC26A2-deficient chondrodysplasias.	STAT1 HSPA5 ATF6 HHIP	2.01e-05	26	218	4	30685387
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	SETX CENPE BCORL1 RNF40 GIT2 UBN1 TNRC6A PML OBSL1 CEP192 NCKAP5L PAPOLG SETD2 ZMYM4	2.35e-05	588	218	14	38580884
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SRRM1 SETX ZC3H13 BCORL1 RNF40 ACTL6A CDKAL1 PRDM2 DST UBN1 HSPA5 DEAF1 TCF20 GOSR1 CEP290 BAG2 SIN3A ZNF106 SETD2 BAZ1A NOM1 ZMYM4	2.41e-05	1294	218	22	30804502
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	ABCA13 SPTAN1 SYNPO ACTL6A STRIP2 DST FEN1 MAP3K7 PML DYRK3 BAG2 APOB ZMYM4	2.43e-05	513	218	13	25798074
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	KIF21B ZC3H13 SPTAN1 DST PLCB1 MXRA5 ARHGEF12 SETD2	2.56e-05	187	218	8	26460568
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	SRRM1 RAB11B THNSL1 CENPE GCDH CDKAL1 STX5 DST PMPCA MIB1 MAP3K7 ALDH5A1 SUN1 BAG2 OBSL1 LRRC40 VARS2 ATF6 AKAP9 NOM1 BRD7 CDK5RAP2 MARK2 ESPL1	2.58e-05	1496	218	24	32877691
Pubmed	The splicing regulator PTBP2 controls a program of embryonic splicing required for neuronal maturation.	KIF21B MAGI1 NES ARHGEF12	2.73e-05	28	218	4	24448406
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	RAB11A ITGAV ZDHHC8 CEMIP2 DST PTPRM PLCB1 UTRN ZDHHC5 CD22 MARK2	2.92e-05	377	218	11	38117590
Pubmed	GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier.	NES ITGAV SLIT2 ADGRA3 TIMP1	3.51e-05	59	218	5	21421844
Pubmed	Polymorphism in nucleotide excision repair gene XPC correlates with bleomycin-induced chromosomal aberrations.	ERCC2 ERCC4 XRCC2	3.86e-05	11	218	3	17685459
Pubmed	High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.	C4A C4B	3.91e-05	2	218	2	19062096
Pubmed	Antigen-induced B cell apoptosis is independent of complement C4.	C4A C4B	3.91e-05	2	218	2	17645767
Pubmed	Phospholipase C-related but catalytically inactive protein acts as a positive regulator of insulin signalling in adipocytes.	PLCL2 PLCL1	3.91e-05	2	218	2	34859819
Pubmed	Anti-DNA autoreactivity in C4-deficient mice.	C4A C4B	3.91e-05	2	218	2	12207352
Pubmed	Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.	C4A C4B	3.91e-05	2	218	2	27758680
Pubmed	Phospholipase C-related catalytically inactive protein regulates lipopolysaccharide-induced hypothalamic inflammation-mediated anorexia in mice.	PLCL2 PLCL1	3.91e-05	2	218	2	31589911
Pubmed	Hypoxia-inducible factor-2alpha transactivates Abcg2 and promotes cytoprotection in cardiac side population cells.	ABCG2 EPAS1	3.91e-05	2	218	2	18356544
Pubmed	A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1.	CEACAM5 TIMP1	3.91e-05	2	218	2	20095885
Pubmed	Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.	C4A C4B	3.91e-05	2	218	2	3037333
Pubmed	Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.	C4A C4B	3.91e-05	2	218	2	11726230
Pubmed	Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.	C4A C4B	3.91e-05	2	218	2	4216347
Pubmed	Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.	C4A C4B	3.91e-05	2	218	2	8428773
Pubmed	Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.	C4A C4B	3.91e-05	2	218	2	24638111
Pubmed	Transcriptional repression of C4 complement by hepatitis C virus proteins.	C4A C4B	3.91e-05	2	218	2	21345967
Pubmed	Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion.	ABCA1 APOB	3.91e-05	2	218	2	28694219
Pubmed	The complement component C4 of mammals.	C4A C4B	3.91e-05	2	218	2	2302180
Pubmed	Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.	C4A C4B	3.91e-05	2	218	2	22151770
Pubmed	Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.	C4A C4B	3.91e-05	2	218	2	29080553
Pubmed	C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.	C4A C4B	3.91e-05	2	218	2	25339671
Pubmed	A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.	C4A C4B	3.91e-05	2	218	2	17728371
Pubmed	Structure and organization of the C4 genes.	C4A C4B	3.91e-05	2	218	2	6149580
Pubmed	Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.	C4A C4B	3.91e-05	2	218	2	6149581
Pubmed	Biochemistry and biology of anaphylatoxins.	C4A C4B	3.91e-05	2	218	2	3542363
Pubmed	C4 from C4-high and C4-low mouse strains have identical sequences in the region corresponding to the isotype-specific segment of human C4.	C4A C4B	3.91e-05	2	218	2	2387317
Pubmed	Structural studies on the murine fourth component of complement (C4). IV. Demonstration that C4 and Slp are encoded by separate loci.	C4A C4B	3.91e-05	2	218	2	7365238
Pubmed	Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis.	AKR1C1 AKR1C3	3.91e-05	2	218	2	30367463
Pubmed	Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.	C4A C4B	3.91e-05	2	218	2	17971360
Pubmed	Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.	C4A C4B	3.91e-05	2	218	2	17971229
Pubmed	HIF-KDM3A-MMP12 regulatory circuit ensures trophoblast plasticity and placental adaptations to hypoxia.	KDM3A MMP12	3.91e-05	2	218	2	27807143
Pubmed	Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.	C4A C4B	3.91e-05	2	218	2	35898513
Pubmed	The link of ERCC2 rs13181 and ERCC4 rs2276466 polymorphisms with breast cancer in the Bangladeshi population.	ERCC2 ERCC4	3.91e-05	2	218	2	34837148
Pubmed	Borrelia burgdorferi outer surface protein C (OspC) binds complement component C4b and confers bloodstream survival.	C4A C4B	3.91e-05	2	218	2	28873507
Pubmed	Recombination of two homologous MHC class III genes of the mouse (C4 and Slp) that accounts for the loss of testosterone dependence of sex-limited protein expression.	C4A C4B	3.91e-05	2	218	2	3794341
Pubmed	The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling.	STAT1 PML	3.91e-05	2	218	2	17121994
Pubmed	Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.	ABCG2 EPAS1	3.91e-05	2	218	2	30536571
Pubmed	Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes.	C4A C4B	3.91e-05	2	218	2	22785613
Pubmed	Association between complement 4 copy number variation and systemic lupus erythematosus: a meta-analysis.	C4A C4B	3.91e-05	2	218	2	32691186
Pubmed	Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals.	CEACAM5 TIMP1	3.91e-05	2	218	2	26254391
Pubmed	The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter.	C4A C4B	3.91e-05	2	218	2	8390682
Pubmed	Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp).	C4A C4B	3.91e-05	2	218	2	3902619
Interaction	MED4 interactions	KIF21B SRRM1 CENPE ZC3H13 SPTAN1 RNF40 ACTL6A GIT2 SPICE1 CCDC66 DST MIB1 TNRC6A MAP3K7 UTRN RGPD5 CEP290 LRRCC1 EPAS1	3.65e-07	450	214	19	int:MED4
Cytoband	10p15-p14	AKR1C1 KIN AKR1C3	2.09e-06	6	218	3	10p15-p14
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA2B ITGAV ITGA11	4.17e-04	18	150	3	1160
GeneFamily	Phospholipases\|C2 domain containing phospholipases	PLCL2 PLCB1 PLCL1	4.92e-04	19	150	3	832
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	CENPE ITGA2B UBN1 PLCL1 CEP192 AKAP9 NOM1	7.94e-04	181	150	7	694
GeneFamily	WD repeat domain containing\|ERCC excision repair associated	ERCC2 ERCC4	1.40e-03	7	150	2	1268
GeneFamily	EF-hand domain containing\|Plakins	EVPL DST	1.85e-03	8	150	2	939
GeneFamily	WD repeat domain containing\|Xeroderma pigmentosum complementation groups\|Nucleotide excision repair	ERCC2 ERCC4	1.85e-03	8	150	2	1125
GeneFamily	DNAJ (HSP40) heat shock proteins\|C2 tensin-type domain containing	TNS3 TNS2	1.85e-03	8	150	2	837
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	CEACAM5 SPEG PTPRM ADGRA3 MXRA5 OBSL1	2.26e-03	161	150	6	593
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C4A C4B	2.37e-03	9	150	2	1234
GeneFamily	Glycosyltransferase family 6\|Blood group antigens	C4A C4B ABCG2	3.54e-03	37	150	3	454
GeneFamily	UPF1 like RNA helicases	SETX ZNFX1	3.58e-03	11	150	2	1169
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	PDE4D ZC3H13 SLIT2 PTPRM AIG1 SCAPER TNRC6A ULK4 SLC5A12 CUBN AKAP13 MBD5	3.69e-07	221	218	12	M39222
Coexpression	PEREZ_TP53_TARGETS	GPR155 ABCA1 ABCA13 EVPL ITGAV SPICE1 C4A ABCG2 ULK1 MMP12 BRWD1 FLNC MXRA5 TRIM2 DEAF1 TMEM204 SUN1 AFF3 ZNFX1 TRIM3 ZNF248 FRY AKAP9 KIN IL20 BRD7 C1QTNF12	2.78e-06	1201	218	27	M4391
Coexpression	GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP	SPAG1 STAT1 HERC6 PML TNS2 ZNFX1 TDRD7 BAZ1A CD40 ESPL1	5.11e-06	192	218	10	M9509
Coexpression	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	RGPD5 DEAF1 ARHGEF12 DZANK1 FRY SMARCA2	5.12e-06	53	218	6	M8077
Coexpression	LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX	MAGI1 PDE4D ITGAV SLIT2 TFCP2L1 SCAPER PLCL1 TRIM2 AKAP9	5.42e-06	152	218	9	M39239
Coexpression	GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN	CEACAM5 CENPE ZC3H13 SPICE1 SCAPER ALDH5A1 DYRK3 LIG1 FRY BAZ1A	6.70e-06	198	218	10	M8355
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	PDE4D ERCC4 SPEG SYNPO STAT1 NOD1 DST TULP4 PTPRM NAV2 C4A C4B ULK1 DENND5A TRIM2 DEAF1 CEP192 PMEL CUBN COA8 SEMA4G SMARCA2 PCNX1 ARHGAP28 ZNF445	8.05e-06	1124	218	25	MM1070
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	KDM3A SETX CENPE SLIT2 DST PTPRM SYNJ2 DENND5A ADGRA3 ANKS1A NPAT TRIM2 TDRD7 RSBN1 SETD2 AKAP9 KIN BAZ1A SMARCA2 AKAP13 ZMYM4	1.06e-05	856	218	21	M4500
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	KDM3A ACACB PRDM2 SCAPER TNRC6A NAV2 VWF VARS2 FRY	1.11e-05	166	218	9	M6826
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	NES ITGAV DST PTPRQ MIB1 UTRN ARHGEF12 FRY ARHGAP28 MBD5	1.22e-05	212	218	10	M39221
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	PDE4D ERCC4 SPEG SYNPO STAT1 NOD1 DST TULP4 PTPRM NAV2 C4A ULK1 DENND5A TRIM2 DEAF1 CEP192 PMEL CUBN COA8 SEMA4G SMARCA2 PCNX1 ARHGAP28 ZNF445	1.74e-05	1102	218	24	M2369
Coexpression	SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP	HLA-DRB5 TLR8 STAT1 CD40	2.49e-05	21	218	4	M41167
Coexpression	LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR	DST PTPRM PLCB1 UTRN HSPA5 ABI3BP AKAP13 EPAS1	4.23e-05	152	218	8	M39243
Coexpression	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	GPR155 STAT1 PLCB1 ADGRA3 TNS3 FRY SMARCA2 AKR1C3 MBD5	4.28e-05	197	218	9	M9862
Coexpression	HALLMARK_MITOTIC_SPINDLE	CENPE SPTAN1 SYNPO DST ARHGEF12 CEP192 CDK5RAP2 AKAP13 ESPL1	4.63e-05	199	218	9	M5893
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	KIF21B MAGI1 KCTD9 SRRM1 NES CYP4F8 CENPE ZC3H13 SPTAN1 TMEM63B CEMIP2 SLIT2 CCDC66 HERC6 ALDH5A1 DYRK3 BRWD1 TRIM2 FAT3 GOSR1 CEP290 XRCC2 NCKAP5L PAPOLG RSBN1 LIG1 DZANK1 AKAP9 KIN BAZ1A LRRCC1	1.98e-05	1370	214	31	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000	SRRM1 ZC3H13 BCORL1 GIT2 CDKAL1 SLIT2 NAV2 PLCL1 UTRN AFF3 COA8 ZNF445	3.00e-05	281	214	12	gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	ZNF717 SETX THNSL1 SPICE1 PHKA1 SCAPER BRWD1 NPAT ZYG11A SESTD1 ZCWPW1 KIF27 POLA1 TTC27 LRRC40 CEP192 CUBN PAPOLG TDRD7 LIG1 BAZ1A ESPL1	3.02e-05	820	214	22	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000	SRRM1 ZC3H13 SLIT2 TNRC6A NAV2 UTRN CHD8 COA8 RSBN1 ZNF445	5.63e-05	210	214	10	gudmap_developingGonad_e18.5_ovary_1000_k2
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000	GPR155 SRRM1 ZC3H13 BCORL1 SLIT2 GSDME EFEMP1 KCNC2 TNRC6A NAV2 UTRN TRIM2 ABI3BP FAT3 AFF3 OBSL1 CHD8 COA8 HHIP SMARCA2 ZNF445	5.98e-05	797	214	21	gudmap_developingGonad_P2_epididymis_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000	GPR155 RAB11B ACACB CENPE SYNPO CEMIP2 SPICE1 CCDC66 UBN1 LRRTM4 AIG1 UTRN PML CCDC170 GOSR1 CEP290 ARHGEF12 ZNF248 HHIP USF3 AKAP9 BAZ1A BPIFB4 MBD5	6.02e-05	985	214	24	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	SRRM1 ZC3H13 BCORL1 GIT2 CDKAL1 SLIT2 GSDME EFEMP1 TNRC6A NAV2 PLCL1 UTRN ABI3BP FAT3 AFF3 OBSL1 CHD8 COA8 HHIP SMARCA2 ZNF445	6.19e-05	799	214	21	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3	MAGI1 KCTD9 NES ABCA1 TMEM63B GCDH CEMIP2 SLIT2 DST NRXN2 TULP4 LRRTM4 ALDH5A1 TRIM2 FAT3 CEP290 CHD8 ZKSCAN2 SEMA4G PAPOLG DZANK1 AKAP9	1.06e-04	893	214	22	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	RAB11B CENPE CCDC66 GSDME CEP290 CEP192 AKAP9 BAZ1A LRRCC1	1.17e-04	186	214	9	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	SRRM1 ZC3H13 SLIT2 GSDME UBN1 TULP4 LRRTM4 MIB1 SCAPER TNRC6A NAV2 UTRN ABI3BP CEP290 OBSL1 CHD8 COA8 RSBN1 INSYN2B ZNF445	1.26e-04	778	214	20	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500	GPR155 RAB11B ACACB CENPE SYNPO CEMIP2 CCDC66 LRRTM4 UTRN CCDC170 CEP290 ARHGEF12 AKAP9 BAZ1A BPIFB4	1.49e-04	492	214	15	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	ABCA1 ERCC4 SETX TULP4 MIB1 SCAPER MAP3K7 FAT3 RSBN1 HHIP AKAP9 ARHGAP28 ZMYM4	1.54e-04	385	214	13	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	SRRM1 ZC3H13 BCORL1 GIT2 CDKAL1 SLIT2 GSDME TULP4 LRRTM4 TNRC6A NAV2 UTRN FAT3 AFF3 OBSL1 CHD8 COA8 HHIP SMARCA2 ZNF445	1.54e-04	790	214	20	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	GPR155 MAGI1 KCTD9 NES ABCA1 PDE4D ACACB CENPE TMEM63B CEMIP2 SLIT2 NRXN2 LRRTM4 NPR2 TRIM2 FAT3 CEP290 CHD8 ZKSCAN2 PAPOLG AKAP9 BAZ1A LRRCC1	1.64e-04	986	214	23	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	SRRM1 CYP4F8 ERCC2 SETX CENPE ZC3H13 ACTL6A CDKAL1 CCDC66 MAP3K7 ALDH5A1 DYRK3 BRWD1 POLA1 GOSR1 CEP290 CEP192 PAPOLG RSBN1 LIG1 DZANK1 AKAP9 KIN BAZ1A BRD7 LRRCC1 MBD5	1.69e-04	1257	214	27	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	RAB11B CENPE CCDC66 GOSR1 CEP290 ZNF248 HHIP USF3 AKAP9 BAZ1A MBD5	1.89e-04	291	214	11	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2	ZNF717 RAB11B ABCA1 PDE4D SYNPO GIT2 ITGA2B GSDME NOD1 LRRTM4 AIG1 FLNC NPR2 VWF FAT3 GOSR1 AFF3 SIN3A VARS2 NCKAP5L ATF6 TIMP1 SMARCA2 ARHGAP28 MARK2 C1QTNF12	2.18e-04	1208	214	26	facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500	SRRM1 ZC3H13 BCORL1 SLIT2 NAV2 UTRN COA8 ZNF445	2.45e-04	162	214	8	gudmap_developingGonad_e16.5_epididymis_500_k2
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	RAB11B SETX CENPE BCORL1 DST POLA1 CEP290 LRRC40 CEP192 AKAP9 BAZ1A BRD7 LRRCC1 EPAS1	3.07e-04	469	214	14	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	MAGI1 RAB11B CENPE GIT2 CCDC66 MAP3K7 TCF20 GOSR1 CEP290 ARHGEF12 PAPOLG HHIP SETD2 USF3 AKAP9 BAZ1A MBD5 ZMYM4 STX6	3.65e-04	780	214	19	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500	SRRM1 ZC3H13 SLIT2 MIB1 CHD8 COA8 RSBN1 ZNF445	3.66e-04	172	214	8	gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 PDE4D CDKAL1 SLIT2 PTPRM SCAPER TNRC6A PLCL1 SLC5A12 CUBN AKAP13 MBD5	2.12e-10	192	218	12	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	SRRM1 ZC3H13 TFCP2L1 DST UTRN BRWD1 CEP290 ZNF106 AKAP9 BRD7 SMARCA2	4.44e-09	199	218	11	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	PDE4D SLIT2 DST PTPRM NAV2 ULK4 TNS3 FAT3 ZNF106 ARHGAP28	3.98e-08	192	218	10	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	SRRM1 ZC3H13 UTRN CEP290 ZNF106 AKAP9 BAZ1A SMARCA2 AKR1C3 LRRCC1	5.32e-08	198	218	10	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAGI1 GABRP ACACB PTPRM SYNJ2 PLCB1 UTRN VWF EPAS1	2.59e-07	179	218	9	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	STAT1 DST NLRC5 UTRN PML CHD8 ZNFX1 SETD2 BAZ1A	3.13e-07	183	218	9	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	MAGI1 ACACB ITGAV DST PTPRM PLCL1 FLNC FRY AKAP13	3.27e-07	184	218	9	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	COPD-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	SLIT2 EFEMP1 PTPRQ C4A C4B ADGRA3 FLNC ABI3BP IL20	3.43e-07	185	218	9	23579988036fc1925992c31919750f9b3fe9f790
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ABCA1 ACACB CDHR3 ZC3H13 AIG1 TNRC6A PLCB1 TNS3 MBD5	3.75e-07	187	218	9	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	MAGI1 GABRP PDE4D PTPRM SYNJ2 PLCB1 UTRN VWF EPAS1	3.75e-07	187	218	9	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	COPD-Epithelial-Mesothelial\|COPD / Disease state, Lineage and Cell class	SLIT2 EFEMP1 PTPRQ C4A C4B ADGRA3 FLNC ABI3BP IL20	4.10e-07	189	218	9	79bb2593ad5d17f94b17972884241f03a0f43770
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 PDE4D ACACB PLCB1 PLCL1 UTRN TRIM2 FRY MBD5	4.10e-07	189	218	9	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	PCW_13-14\|World / Celltypes from embryonic and fetal-stage human lung	SLIT2 DST PTPRM ABI3BP FAT3 CD22 SMARCA2 ARHGAP28 MBD5	4.29e-07	190	218	9	62a3ec1ae0829602b0569cc051210551644f1d46
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP95 SPAG1 CEACAM5 ABCA13 CDHR3 TFCP2L1 TTLL10 DTHD1 FUT2	4.29e-07	190	218	9	2fdc024d3d673a0134b74b4c5a63afe924995730
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA1 PDE4D CDKAL1 PTPRM DENND5A UTRN TNS3 PCNX1 AKAP13	4.89e-07	193	218	9	779276e775cb2492e8dd36436295a536084a6415
ToppCell	droplet-Fat-Mat-18m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNPO DST PTPRM ABCG2 UTRN VWF TMEM204 FRY EPAS1	4.89e-07	193	218	9	54024a373e42e1c0bcc327dc084564b83b63a9d4
ToppCell	droplet-Fat-Mat-18m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNPO DST PTPRM ABCG2 UTRN VWF TMEM204 FRY EPAS1	4.89e-07	193	218	9	81d908594d2983ba7e7c1ec25afdde4315d9690e
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPAG1 ABCA13 CDHR3 ULK4 TTLL10 DTHD1 CCDC170 KIF27 ECT2L	5.11e-07	194	218	9	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CEMIP2 PTPRM ABCG2 VWF TMEM204 ARHGEF12 FRY SMARCA2 EPAS1	5.11e-07	194	218	9	cceb7c88492bb6cd531e1c2651638da1ddf30931
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CEMIP2 PTPRM ABCG2 VWF TMEM204 ARHGEF12 FRY SMARCA2 EPAS1	5.11e-07	194	218	9	ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP95 SPAG1 ABCA13 CDHR3 STOX1 DTHD1 CCDC170 ECT2L AKAP9	5.81e-07	197	218	9	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP95 SPAG1 ABCA13 CDHR3 STOX1 DTHD1 CCDC170 ECT2L AKAP9	5.81e-07	197	218	9	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDHR3 ULK4 TTLL10 DTHD1 KIF27 CEP290 ECT2L DZANK1 AKAP9	5.81e-07	197	218	9	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP95 SPAG1 ABCA13 CDHR3 STOX1 DTHD1 CCDC170 ECT2L AKAP9	5.81e-07	197	218	9	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP95 SPAG1 ABCA13 CDHR3 STOX1 DTHD1 CCDC170 ECT2L AKAP9	5.81e-07	197	218	9	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GABRP SPAG1 CEACAM5 ABCA13 CDHR3 DTHD1 CCDC170 TRIM2 AKAP9	6.06e-07	198	218	9	d0ecace1fad24ce50b0935036fabb07e6c9e372d
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NES SPTAN1 SYNPO DST PTPRM UTRN VWF ABI3BP EPAS1	6.32e-07	199	218	9	9b02acae6325b0ac9642438a4431285ff396e5fe
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-tip_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MAGI1 NES SYNPO CEMIP2 PTPRM VWF TMEM204 ARHGAP28 EPAS1	6.32e-07	199	218	9	1c69395c9305b6ecb0a826d46c8e8ec95795ad6d
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	MAGI1 NES CEMIP2 PTPRM MIB1 PLCB1 VWF AFF3 EPAS1	6.32e-07	199	218	9	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NES SPTAN1 SYNPO PTPRM UTRN VWF ABI3BP TNS2 EPAS1	6.32e-07	199	218	9	a3ec743b978ba8fdf1677b4971b5731f50ddd30f
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NES SETX SPTAN1 PTPRM AFF3 ARHGEF12 FRY TIMP1 EPAS1	6.59e-07	200	218	9	7034f57e282982c19c13ee8ab78eabaffa069e30
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / Treatment groups by lineage, cell group, cell type	SPTAN1 DST PTPRM SYNJ2 PLCB1 VWF FRY SMARCA2 EPAS1	6.59e-07	200	218	9	b17eb1587ca86c3d40515128a00a8d8fd787fccf
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SETX SPTAN1 DST PTPRM UTRN BRWD1 VWF ARHGEF12 EPAS1	6.59e-07	200	218	9	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Bronchial_Brush-Epithelial-Goblet_1\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	GABRP ABCA1 CEACAM5 VSIG1 ZDHHC8 KCNS3 BPIFB4 ESPL1	1.21e-06	159	218	8	a8fa49dc2e6ad726d1f4f2b30693fecd1151a485
ToppCell	Influenza_Severe-B_memory\|World / Disease group and Cell class	HLA-DRB5 SYNPO ZYG11A SEMA4G HHIP P2RX5 CD22 CD40	1.39e-06	162	218	8	21eb96cd4fecd85dd6acbbc3760944fa1a7cff42
ToppCell	Control-Epithelial-Mesothelial\|Control / Disease state, Lineage and Cell class	SLIT2 EFEMP1 C4A C4B ADGRA3 FLNC ABI3BP IL20	1.67e-06	166	218	8	1ed3788257e14f097862b999f020bfe2a57de52b
ToppCell	Control-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	SLIT2 EFEMP1 C4A C4B ADGRA3 FLNC ABI3BP IL20	1.67e-06	166	218	8	32ebaefa6c074b28193fff764ee7c2c0e9357e20
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	MAGI1 ABCA1 DST PTPRM NAV2 VWF ARHGEF12 EPAS1	2.00e-06	170	218	8	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACACB SYNPO CEMIP2 PTPRM VWF ABI3BP EPAS1	2.01e-06	119	218	7	c3f1223356e7f245a460ea5568a223e34e458dc1
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ABCA1 TMEM63B EFEMP1 DST CEP192 ZNF106 FRY CDK5RAP2	2.48e-06	175	218	8	334fad1a147de6c007cec5089c02c35cf3220f1b
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	ABCA1 TMEM63B EFEMP1 DST CEP192 ZNF106 FRY CDK5RAP2	2.48e-06	175	218	8	da191dfb8a7f976a632a3a0b923942ab54f5c8c1
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CEMIP2 STRIP2 PTPRM FEN1 PLCB1 TMEM204 LIG1 EPAS1	2.58e-06	176	218	8	269326c2bf44a9003d95bc6dbc839f08f25737ca
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE4D ACACB GIT2 STAT1 PLCL2 MUC19 FRY SMARCA2	2.93e-06	179	218	8	d3438fed0d85d5ed5afa8ff820c45143d77b6c0d
ToppCell	IPF-Epithelial-Mesothelial\|IPF / Disease state, Lineage and Cell class	SLIT2 EFEMP1 PTPRQ C4A C4B FLNC ABI3BP IL20	3.05e-06	180	218	8	1fa54bf4dba72866b2295639d991af639341bc08
ToppCell	severe_influenza-B_memory\|severe_influenza / disease group, cell group and cell class (v2)	HLA-DRB5 VSIG1 SYNPO ZYG11A AFF3 P2RX5 CD22 CD40	3.18e-06	181	218	8	92e572c92109a6dae0f73138c57c3bbd2e0a2f36
ToppCell	IPF-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	SLIT2 EFEMP1 PTPRQ C4A C4B FLNC ABI3BP IL20	3.45e-06	183	218	8	7df20e3172a1220ff427f30181f4f0c3b7fe2d42
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CEMIP2 DST ABCG2 UTRN VWF ABI3BP TNS2 EPAS1	3.45e-06	183	218	8	fc9a7ba148c22d0c8a46f6bc56c772929ac496f7
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDHR3 TTLL10 DTHD1 DYRK3 CCDC170 FLNC ITGA11 KIF27	3.59e-06	184	218	8	264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDHR3 TTLL10 DTHD1 DYRK3 CCDC170 FLNC ITGA11 KIF27	3.59e-06	184	218	8	d7eccbd21c480d907fdc8eff2bf5ae22ae452221
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDHR3 TTLL10 DTHD1 DYRK3 CCDC170 FLNC ITGA11 KIF27	3.59e-06	184	218	8	22010cfe0428ebfa40952cc1a1a12ad3d25b35c9
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ABCA1 ACACB CDHR3 PTPRM AIG1 PLCB1 TNS3 KIAA1755	3.74e-06	185	218	8	1d874608aa2062024323512f68889219471b2f00
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EFEMP1 PTPRQ C4A C4B FLNC ABI3BP TIMP1 IL20	3.89e-06	186	218	8	7812ed80d2378aca9957ef22fc3c8fb7fb58434b
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NES SYNPO ITGAV DST PTPRQ MIB1 FRY ARHGAP28	4.05e-06	187	218	8	24c2a3962da364e46e98abeab5f8234376fa26bb
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP95 SPAG1 ABCA13 CDHR3 STOX1 TTLL10 DTHD1 CCDC170	4.38e-06	189	218	8	b4b93bd10b7e3cc16e54ff73beac230f519c010a
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NES NOD1 ABCG2 TMEM204 TRIM3 ZNF540 ARHGAP28 EPAS1	4.38e-06	189	218	8	e60a3d6aa84788c29f23439f1c747431ea581bc3
ToppCell	390C-Lymphocytic-B_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HLA-DRB5 PRDM2 GSDME SESTD1 AFF3 P2RX5 CD22 CD40	4.55e-06	190	218	8	f63c9474f23bb72f0bb1fc531342f0da04ed8b3e
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GABRP CEACAM5 STAT1 TFCP2L1 HERC6 TRIM2 FUT2 EPAS1	4.55e-06	190	218	8	6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAGI1 RAB11A ITGA2B AKR1C1 UTRN FLNC VWF AKR1C3	4.55e-06	190	218	8	b2bd2cb384bb8a5662064ed1aee68e905e1f780d
ToppCell	390C-Lymphocytic-B_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HLA-DRB5 PRDM2 GSDME SESTD1 AFF3 P2RX5 CD22 CD40	4.55e-06	190	218	8	53bf211f0e8a44f5adb89c43b210a1e35120b6a8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NES SYNPO ITGAV PTPRQ HSPA5 FRY TIMP1 ARHGAP28	4.55e-06	190	218	8	92710caaff05123cf8e909319d7ac441d9b31a66
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES SPTAN1 DST UTRN ARHGEF12 AKAP9 SMARCA2 EPAS1	4.55e-06	190	218	8	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	MAGI1 ACACB DST PTPRM PLCL2 PLCL1 ECT2L AKAP13	4.73e-06	191	218	8	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCA1 CEMIP2 SLIT2 NOD1 SYNJ2 ADGRA3 FAT3 TIMP1	4.73e-06	191	218	8	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	PDE4D CDKAL1 SYNJ2 TNRC6A PLCB1 UTRN AKAP9 MBD5	4.92e-06	192	218	8	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	SLIT2 PLCB1 ITGA11 VWF ABI3BP TIMP1 KIAA1755 EPAS1	4.92e-06	192	218	8	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP95 SPAG1 CDHR3 STOX1 TTLL10 DTHD1 CCDC170 ECT2L	4.92e-06	192	218	8	1b6cac8156e608061e1405e36e18d185b6fa8f6f
ToppCell	mild_COVID-19-B_memory\|World / disease group, cell group and cell class (v2)	HLA-DRB5 SYNPO PRDM2 ZYG11A AFF3 P2RX5 CD22 CD40	5.11e-06	193	218	8	69b70c838328fdc7dbb6b5449fe2811a5389a839
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	PDE4D CDKAL1 SYNJ2 TNRC6A PLCB1 UTRN AKAP9 MBD5	5.11e-06	193	218	8	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP95 SPAG1 ABCA13 CDHR3 TTLL10 DTHD1 CCDC170 ECT2L	5.11e-06	193	218	8	e1b76102f812c433195d1e8811fdd3293a7bc22e
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NES SYNPO ITGAV DST PTPRQ MIB1 FRY ARHGAP28	5.11e-06	193	218	8	3eaa0461618582a1754400624350d269d24e750a
ToppCell	mild_COVID-19-B_memory\|mild_COVID-19 / disease group, cell group and cell class (v2)	HLA-DRB5 SYNPO PRDM2 ZYG11A AFF3 P2RX5 CD22 CD40	5.11e-06	193	218	8	7e6fe70928a50b0a8f12220e572c07c5670d092e
ToppCell	RA\|World / Chamber and Cluster_Paper	PDE4D AKR1C1 CEMIP2 PTPRQ NAV2 ULK4 SLC5A12 TIMP1	5.31e-06	194	218	8	08f0afbb68a63150fbe107a5337299081c3f69e4
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EFEMP1 PTPRQ C4A FLNC ABI3BP TIMP1 IL20 ARHGAP28	5.31e-06	194	218	8	421344cc4b601d9745fa72d0af3124dab11d1d27
ToppCell	droplet-Fat-Mat-18m-Endothelial-Cd36+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNPO DST PTPRM ABCG2 UTRN VWF TMEM204 EPAS1	5.31e-06	194	218	8	74d0eaa76f6d9af14110dfe5b4bf9751b99ff6e3
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES CEMIP2 PTPRM PLCB1 TMEM204 ARHGEF12 SMARCA2 EPAS1	5.31e-06	194	218	8	c6cee7d15af76f9a60d7f414ef0bcc1735c47b7a
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	MAGI1 PDE4D CDHR3 NAV2 DTHD1 TRIM2 ARHGEF12 ECT2L	5.51e-06	195	218	8	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	MAGI1 PDE4D CDHR3 NAV2 DTHD1 TRIM2 ARHGEF12 ECT2L	5.51e-06	195	218	8	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP95 SPAG1 ABCA13 CDHR3 TTLL10 DTHD1 CCDC170 ECT2L	5.51e-06	195	218	8	9651ee03738226ee10e901f8b9ec6a417eb9c301
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CEMIP2 PTPRM ABCG2 VWF TMEM204 FRY C1QTNF12 EPAS1	5.51e-06	195	218	8	4658fb197657d7692ee344ae76b11b0210c418ba
ToppCell	Mild-CD8+_T_activated\|World / Disease group and Cell class	GPR155 SETX STAT1 NLRC5 HERC6 UTRN PML ZNFX1	5.72e-06	196	218	8	79632190e44fcef9d7c11d9b9e37f2ebf0e6e255
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 PDE4D CDKAL1 PTPRM SCAPER NAV2 AFF3 MBD5	5.72e-06	196	218	8	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	NS-moderate-d_07-13-Epithelial-Secretory\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GABRP ABCA13 AKR1C1 TFCP2L1 HERC6 AKR1C3 FUT2 EPAS1	5.72e-06	196	218	8	47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea
ToppCell	Bronchial_Brush-Epithelial\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	CFAP95 SPAG1 ABCA13 CDHR3 DTHD1 CCDC170 TRIM2 AKAP9	5.94e-06	197	218	8	272c7f4e582ef57564450540242b0db766b78328
ToppCell	5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NES SYNPO PTPRM PLCB1 VWF TMEM204 TNS2 EPAS1	5.94e-06	197	218	8	c29ed0e706999d4c2b93e6e3bf46c42aeceb4813
ToppCell	ILEUM-inflamed-(7)_CD36+_endothelial_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MAGI1 NES SYNPO PTPRM VWF TMEM204 TNS2 EPAS1	6.17e-06	198	218	8	05d6558c7990ad2277db999025a073d29b273dfc
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABCG2 ANKS1A VWF TMEM204 TNS2 FRY AKR1C3 EPAS1	6.17e-06	198	218	8	0a4626b51ba8b52acbaf616f0ced850079cd7149
ToppCell	severe-B_memory\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SPAG1 HLA-DRB5 SYNPO PRDM2 AFF3 P2RX5 CD22 CD40	6.17e-06	198	218	8	88649dc642193bda5e8eff3f79c832807d5e200a
ToppCell	tumor_Lung-Endothelial_cells-Tumor_ECs\|tumor_Lung / Location, Cell class and cell subclass	MAGI1 NES SYNPO PLCB1 VWF TMEM204 FRY EPAS1	6.17e-06	198	218	8	5228c4bf2513186140c2c4eaa67a268c732bdc84
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TFCP2L1 PLCB1 NAV2 PLCL1 HSPA5 TRIM2 OBSL1 AKAP9	6.17e-06	198	218	8	4448d13511485a44fe7b549e4b8b6ad7637db624
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 PDE4D CDKAL1 PTPRM SCAPER NAV2 AFF3 MBD5	6.17e-06	198	218	8	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NES HLA-DRB5 SYNPO UTRN VWF ABI3BP TNS2 EPAS1	6.40e-06	199	218	8	f35e9c05d0a0339ff691b38564da7aad8e9218aa
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	SRRM1 SETX ZC3H13 HLA-DRB5 TFCP2L1 CEP290 AKAP9 BAZ1A	6.40e-06	199	218	8	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	SRRM1 SETX ZC3H13 TFCP2L1 CEP290 AKAP9 BAZ1A SMARCA2	6.40e-06	199	218	8	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 PDE4D CDKAL1 SCAPER TNRC6A UTRN AFF3 MBD5	6.40e-06	199	218	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-B-B_memory\|COVID-19_Mild / Disease, condition lineage and cell class	HLA-DRB5 SYNPO PRDM2 ZYG11A AFF3 P2RX5 CD22 CD40	6.40e-06	199	218	8	54e392b4ebe601d4838739ff7de3ac6b2203c948
ToppCell	NS-moderate-d_16-33-Epithelial\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SPAG1 CEACAM5 ABCA13 AKR1C1 TRIM2 AKR1C3 FUT2 EPAS1	6.40e-06	199	218	8	aa2b51940115c22768c0d7493b4b60d41df3f376
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	ZC3H13 FAT3 CEP290 ARHGEF12 AKAP9 BRD7 SMARCA2 EPAS1	6.40e-06	199	218	8	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	AKR1C1 ABCG2 VWF TMEM204 CUBN FRY AKR1C3 EPAS1	6.40e-06	199	218	8	c5c12c8288fe868322bae9d691b91fee953ceb3e
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NES SYNPO PTPRM SYNJ2 FLNC VWF ABI3BP EPAS1	6.40e-06	199	218	8	6a2943a23fdd2ec814662db7c21a0d6804a6cbbc
ToppCell	NS-moderate-d_07-13-Epithelial\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GABRP CEACAM5 ABCA13 AKR1C1 TRIM2 AKR1C3 FUT2 EPAS1	6.64e-06	200	218	8	85940b4bf7971b872469dea8b8d7a45bdeb2a909
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	MAGI1 ERCC4 NOD1 TMEM259 NAV2 ALDH5A1 PML CCDC170 XRCC2 DZANK1 PCNX1 AKAP13	4.04e-07	196	216	12	3268_DN
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; PC3; HT_HG-U133A	ERCC2 ACACB EVPL SYNPO GIT2 CEMIP2 SCAPER PLCB1 PML NPR2 TRIM2 ESPL1	4.75e-07	199	216	12	6308_DN
Drug	estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	ERCC2 STAT1 SCAPER PLCB1 HERC6 UTRN PML DYRK3 TRIM2 TRIM3 ATF6 AKAP13	4.75e-07	199	216	12	988_UP
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	ABCA1 PRDM2 EFEMP1 SYNJ2 SCAPER PLCB1 SUN1 CEP290 PAPOLG SETD2 AKAP13	2.25e-06	191	216	11	4269_DN
Drug	Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A	GIT2 SYNJ2 AIG1 TNS3 NPR2 DEAF1 TRIM3 LIG1 DZANK1 SMARCA2 AKAP13	2.90e-06	196	216	11	1696_DN
Drug	Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; PC3; HT_HG-U133A	GCDH GIT2 CEMIP2 KCNS3 UTRN PML BRWD1 DEAF1 SEMA4G AKAP9 CD40	3.04e-06	197	216	11	5843_UP
Drug	Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A	CDKAL1 NOD1 PTPRM PLCB1 UTRN PML DYRK3 ARHGEF12 SEMA4G PAPOLG FUT2	3.19e-06	198	216	11	6777_UP
Drug	estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A	SCAPER NAV2 HERC6 DYRK3 NPR2 TRIM2 SUN1 CEP290 AFF3 DZANK1 ZNF749	3.19e-06	198	216	11	6968_UP
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A	KIF21B RAB11B SPAG1 ERCC2 GCDH ULK1 ALDH5A1 PML SIGLEC7 CD22 CD40	3.19e-06	198	216	11	6183_DN
Drug	Gliquidone [33342-05-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A	ERCC2 MATN1 SYNPO GSDME PLCL2 PLCB1 UTRN PML PMEL TRIM3 CD40	3.35e-06	199	216	11	6505_UP
Drug	Proxyphylline [603-00-9]; Up 200; 16.8uM; PC3; HT_HG-U133A	ERCC4 PRDM2 UBN1 SYNJ2 SCAPER ZCWPW1 ARHGEF12 CD40 AKAP13 ARHGAP28 FUT2	3.35e-06	199	216	11	7290_UP
Drug	Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; HL60; HT_HG-U133A	ABCA1 SPTAN1 ITGAV CEMIP2 GSDME PLCB1 TRIM3 SIGLEC7 TIMP1 AKAP13	4.17e-06	165	216	10	2136_UP
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	SETX PRDM2 PLCL2 NAV2 ANKS1A NPAT RSBN1 SETD2 KIN BAZ1A	9.00e-06	180	216	10	4541_DN
Drug	Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A	CEACAM5 GIT2 PLCB1 PML TRIM2 SUN1 PMEL SEMA4G TRIM3 MARK2	9.92e-06	182	216	10	7422_UP
Drug	Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A	RAB11B ABCA1 SPTAN1 PTPRM SYNJ2 PLCB1 ZCWPW1 DEAF1 CD22 AKR1C3	1.51e-05	191	216	10	3582_UP
Drug	Cefalonium [5575-21-3]; Up 200; 8.8uM; MCF7; HT_HG-U133A	ABCA1 SPTAN1 GIT2 PLCB1 PML DEAF1 GOSR1 ARHGEF12 PMEL TRIM3	1.65e-05	193	216	10	7341_UP
Drug	1,2,5,6-dibenzanthracene	NES ABCA1 CEACAM5 CENPE AKR1C1 CEMIP2 TFCP2L1 TULP4 FEN1 KCNS3 SLC5A12 HERC6 UTRN DYRK3 TRIM2 VWF ABI3BP HHIP TIMP1 SMARCA2 CDH17 ZNF445	1.67e-05	837	216	22	ctd:C026486
Drug	Ivermectin [70288-86-7]; Down 200; 4.6uM; MCF7; HT_HG-U133A	MAGI1 BCORL1 SLIT2 SYNJ2 KCNS3 DYRK3 SUN1 SEMA4G TRIM3 STX6	1.73e-05	194	216	10	2213_DN
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; PC3; HT_HG-U133A	PLCL2 SCAPER UTRN ALDH5A1 PML ZCWPW1 SUN1 ATF6 CD22 SMARCA2	1.81e-05	195	216	10	4508_DN
Drug	colchicine; Down 200; 1uM; SKMEL5; HG-U133A	GCDH ACTL6A GIT2 TNS3 PML TRIM2 GOSR1 LIG1 P2RX5 ZMYM4	1.81e-05	195	216	10	630_DN
Drug	Tetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A	RAB11B ACACB CDKAL1 PRDM2 SLIT2 ABI3BP TNS2 XRCC2 SEMA4G PCNX1	1.89e-05	196	216	10	2888_DN
Drug	Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; PC3; HT_HG-U133A	RAB11B SETX GIT2 TMEM259 AIG1 ABCG2 PML BRWD1 TRIM2 PCNX1	1.89e-05	196	216	10	5807_UP
Drug	Ald1.1-H_000455; Down 200; 10uM; PC3; HT_HG-U133A	MAGI1 STAT1 TULP4 SCAPER PLCB1 MAP3K7 ALDH5A1 ARHGEF12 TRIM3 SMARCA2	1.89e-05	196	216	10	7520_DN
Drug	Ajmaline [4360-12-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A	EVPL CEMIP2 NRXN2 SYNJ2 PLCB1 CEP290 TNS2 DZANK1 PCNX1 AKAP13	1.97e-05	197	216	10	7484_UP
Drug	Suprofen [40828-46-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	MAGI1 SYNJ2 SCAPER PLCB1 HERC6 PML SUN1 ATF6 AKAP9 SMARCA2	1.97e-05	197	216	10	3343_DN
Drug	Naloxone hydrochloride [357-08-4]; Up 200; 11uM; MCF7; HT_HG-U133A	ACACB ITGA2B CDKAL1 NOD1 SYNJ2 SCAPER DYRK3 NPR2 CEP290 PCNX1	1.97e-05	197	216	10	1506_UP
Drug	Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A	RAB11B ERCC4 GCDH AIG1 PLCB1 PML SUN1 TRIM3 CD40 SMARCA2	1.97e-05	197	216	10	3335_DN
Drug	Minoxidil [38304-91-5]; Down 200; 19.2uM; PC3; HT_HG-U133A	ACACB SPTAN1 STAT1 PLCB1 ZCWPW1 CEP290 ARHGEF12 SMARCA2 PCNX1 AKAP13	1.97e-05	197	216	10	4216_DN
Drug	forskolin; Up 200; 50uM; MCF7; HT_HG-U133A_EA	RAB11B CEACAM5 ACACB STAT1 NAV2 ATF6 AKAP9 AKR1C3 EPAS1	1.98e-05	157	216	9	913_UP
Drug	Doxycycline hydrochloride [10592-13-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A	ERCC4 THNSL1 PTPRM PLCB1 UTRN PML NPR2 XRCC2 ZNF106 CD22	2.06e-05	198	216	10	3479_UP
Drug	ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A	NES RAB11B GSDME PLCL2 UTRN PML ZCWPW1 CEP290 SEMA4G EPAS1	2.06e-05	198	216	10	6925_UP
Drug	Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A	THNSL1 EVPL CDKAL1 SLIT2 SYNJ2 TMEM259 PLCB1 TNS2 CD22 SMARCA2	2.06e-05	198	216	10	6790_DN
Drug	Antipyrine [60-80-0]; Down 200; 21.2uM; MCF7; HT_HG-U133A	CDKAL1 PLCB1 UTRN DYRK3 CCDC170 NPR2 TRIM2 TRIM3 ATF6 MARK2	2.15e-05	199	216	10	1489_DN
Drug	Acenocoumarol [152-72-7]; Down 200; 11.4uM; PC3; HT_HG-U133A	SPEG SYNPO STAT1 SYNJ2 BRWD1 TRIM2 ATF6 DZANK1 SMARCA2 ZNF124	2.15e-05	199	216	10	2077_DN
Drug	Ifosfamide [3778-73-2]; Down 200; 15.4uM; MCF7; HT_HG-U133A	BCORL1 STAT1 CDKAL1 AIG1 HERC6 ABI3BP GOSR1 TNS2 DZANK1 SETD2	2.15e-05	199	216	10	3485_DN
Drug	Corynanthine hydrochloride [66634-44-4]; Up 200; 10.2uM; PC3; HT_HG-U133A	MAGI1 MATN1 ITGA2B UBN1 LRRTM4 SLC5A12 CCDC170 NPR2 PAPOLG FUT2	2.25e-05	200	216	10	4227_UP
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	STX5 PLCL2 NAV2 TNS3 ANKS1A CEP192 ZNF248 AKAP9 AKAP13	3.89e-05	171	216	9	7535_DN
Drug	5-oxopentanoic acid	GCDH ALDH5A1 APOB	4.55e-05	8	216	3	CID000439963
Drug	Ac-rgds-nh2	ITGA2B ITGAV VWF	4.55e-05	8	216	3	CID003081210
Drug	17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A	RAB11B PRDM2 TMEM259 HSPA5 PML TRIM2 BAG2 AKAP9 AKR1C3	5.09e-05	177	216	9	1643_UP
Drug	SAHA; Up 200; 10uM; MCF7; HT_HG-U133A	NES SPTAN1 BCORL1 SCAPER DYRK3 TRIM2 PMEL DZANK1 EPAS1	5.09e-05	177	216	9	6980_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	KIF21B NES GCDH PML DYRK3 TRIM2 PMEL TRIM3 EPAS1	6.05e-05	181	216	9	5987_UP
Drug	tirapazamine	ABCA1 ERCC4 XRCC2 SETD2 EPAS1	7.33e-05	46	216	5	CID000033776
Drug	geldanamycin; Up 200; 1uM; PC3; HT_HG-U133A	ABCA1 ZC3H13 SPTAN1 TMEM259 HSPA5 TRIM2 ABI3BP AKAP9 CD40	7.46e-05	186	216	9	1228_UP
Drug	Corticosterone [50-22-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A	ERCC4 TMEM259 SCAPER ALDH5A1 PML DEAF1 XRCC2 SETD2 MARK2	7.78e-05	187	216	9	3244_DN
Drug	Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A	ERCC4 EVPL CDKAL1 ALDH5A1 TNS2 XRCC2 ATF6 AKAP9 PCNX1	8.44e-05	189	216	9	2790_DN
Drug	17-AAG; Up 200; 1uM; PC3; HT_HG-U133A	ABCA1 SYNPO GIT2 SPICE1 HSPA5 SUN1 AFF3 PMEL ARHGAP28	8.44e-05	189	216	9	4430_UP
Drug	Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A	RAB11B ABCA1 ZC3H13 STAT1 CDKAL1 TMEM259 PLCB1 PML ATF6	8.44e-05	189	216	9	5254_DN
Drug	Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; MCF7; HT_HG-U133A	SPTAN1 STAT1 CDKAL1 SYNJ2 PLCB1 UTRN DEAF1 SUN1 TRIM3	8.44e-05	189	216	9	3371_DN
Drug	trichostatin A; Up 200; 0.1uM; MCF7; HG-U133A	NES SPEG SLIT2 STX5 DYRK3 NPAT TRIM2 DZANK1 CDH17	8.79e-05	190	216	9	331_UP
Drug	alpha-methylcinnamic acid	AKR1C1 AKR1C3	8.96e-05	2	216	2	ctd:C510582
Drug	Metergoline [17692-51-2]; Up 200; 10uM; MCF7; HT_HG-U133A	KIF21B PLCL2 SCAPER NAV2 PML ZCWPW1 TRIM2 DEAF1 PCNX1	9.15e-05	191	216	9	5344_UP
Drug	0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A	ACACB SCAPER PLCB1 UTRN PML TRIM2 XRCC2 MARK2 ESPL1	9.15e-05	191	216	9	4289_DN
Drug	Quinacrine dihydrochloride dihydrate [6151-30-0]; Up 200; 7.8uM; MCF7; HT_HG-U133A	ABCA1 CDKAL1 TFCP2L1 LRRTM4 PLCB1 ARHGEF12 PMEL TRIM3 CD40	9.52e-05	192	216	9	3179_UP
Drug	0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A	RAB11B ABCA1 CDKAL1 NOD1 AIG1 NAV2 NPR2 SUN1 EPAS1	9.52e-05	192	216	9	3858_DN
Drug	Isoetharine mesylate salt [7279-75-6]; Up 200; 12uM; PC3; HT_HG-U133A	ABCA1 ACACB GIT2 TFCP2L1 PML SEMA4G TRIM3 PCNX1 EPAS1	9.52e-05	192	216	9	5812_UP
Drug	Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A	GIT2 PRDM2 UBN1 ALDH5A1 CEP290 XRCC2 SETD2 SMARCA2 AKAP13	9.52e-05	192	216	9	4104_DN
Drug	Acetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A	ITGA2B STAT1 PRDM2 NOD1 HERC6 UTRN DYRK3 TRIM2 TDRD7	9.52e-05	192	216	9	1829_UP
Drug	Grgd Peptide	ITGA2B ITGAV VWF	9.62e-05	10	216	3	CID000126679
Drug	IF-7	ERCC2 ERCC4 LIG1	9.62e-05	10	216	3	CID000043188
Drug	Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A	NES RAB11B ZC3H13 SYNJ2 PLCB1 PML XRCC2 AKAP9 PCNX1	9.90e-05	193	216	9	5256_DN
Drug	Fluticasone propionate [80474-14-2]; Down 200; 8uM; MCF7; HT_HG-U133A	ERCC2 CEACAM5 ZC3H13 PRDM2 PLCB1 PML DYRK3 SMARCA2 PCNX1	9.90e-05	193	216	9	4129_DN
Drug	Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	ERCC4 STAT1 SLIT2 SYNJ2 TMEM259 PML DEAF1 SIGLEC7 CD22	9.90e-05	193	216	9	3866_DN
Drug	oxypertine	ITGA2B ITGAV MMP12 ITGA11 VWF	9.96e-05	49	216	5	CID000004640
Drug	Rgd Peptide	CEACAM5 SPEG GCDH ITGA2B ITGAV PTPRM MMP12 ITGA11 VWF TIMP1	1.01e-04	239	216	10	CID000104802
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; MCF7; HT_HG-U133A	RAB11B GCDH STAT1 TMEM259 MAP3K7 NPR2 GOSR1 SETD2 MARK2	1.03e-04	194	216	9	2824_DN
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	ABCA1 PDE4D CDKAL1 HERC6 ALDH5A1 DYRK3 BRWD1 DEAF1 AKAP9	1.03e-04	194	216	9	1185_DN
Drug	Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; PC3; HT_HG-U133A	PRDM2 UBN1 PML BRWD1 TRIM2 SUN1 TNS2 PCNX1 ZNF124	1.03e-04	194	216	9	2087_DN
Drug	Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; MCF7; HT_HG-U133A	SCAPER PLCB1 PML NPR2 SUN1 ARHGEF12 AKAP13 MARK2 ZNF124	1.03e-04	194	216	9	2831_DN
Drug	Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A	ABCA1 PDE4D PRDM2 EFEMP1 AIG1 ABI3BP GOSR1 ARHGEF12 PCNX1	1.03e-04	194	216	9	4309_DN
Drug	Meptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A	RAB11B ERCC2 BCORL1 TLR8 PLCL2 SCAPER PML DYRK3 CEP290	1.07e-04	195	216	9	7326_UP
Drug	Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A	CEACAM5 ACACB NOD1 SCAPER PML DYRK3 CEP290 TRIM3 PCNX1	1.07e-04	195	216	9	1539_UP
Drug	STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A	RAB11B GIT2 ALDH5A1 PML TRIM2 SUN1 SETD2 PCNX1 AKAP13	1.07e-04	195	216	9	6561_UP
Drug	Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A	ERCC4 SYNJ2 TMEM259 SCAPER PLCB1 PML ABI3BP XRCC2 PCNX1	1.07e-04	195	216	9	2278_DN
Drug	Trifluridine [70-00-8]; Up 200; 13.6uM; PC3; HT_HG-U133A	KIF21B RAB11B CYP4F8 GIT2 ITGA2B PLCB1 ABCG2 SMARCA2 PCNX1	1.07e-04	195	216	9	5819_UP
Drug	Cimetidine [51481-61-9]; Down 200; 15.8uM; PC3; HT_HG-U133A	RAB11B ITGA2B PML NPR2 TRIM2 SETD2 CD22 SMARCA2 ZNF749	1.11e-04	196	216	9	4063_DN
Drug	Indomethacin [53-86-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A	ERCC2 GIT2 SLIT2 SCAPER PLCB1 PML TRIM3 SMARCA2 PCNX1	1.11e-04	196	216	9	7409_UP
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; PC3; HT_HG-U133A	BCORL1 ITGA2B SCAPER UTRN TRIM2 CD40 PCNX1 EPAS1 STX6	1.11e-04	196	216	9	2047_UP
Drug	Cefotaxime sodium salt [64485-93-4]; Up 200; 8.4uM; PC3; HT_HG-U133A	RAB11B ACACB STX5 SCAPER ABCG2 CEP290 SEMA4G SETD2 PCNX1	1.11e-04	196	216	9	2072_UP
Drug	Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A	EVPL SCAPER NAV2 PML DYRK3 DEAF1 ATF6 DZANK1 SETD2	1.11e-04	196	216	9	3271_DN
Drug	Enalapril maleate [76095-16-4]; Down 200; 8.2uM; PC3; HT_HG-U133A	RAB11B ACACB SPEG BCORL1 EVPL GCDH STAT1 TRIM2 GOSR1	1.11e-04	196	216	9	7265_DN
Drug	Sulfaguanidine [57-67-0]; Down 200; 18.6uM; PC3; HT_HG-U133A	ACACB SPEG SPTAN1 NOD1 TMEM259 BRWD1 TRIM2 SMARCA2 AKAP13	1.11e-04	196	216	9	4257_DN
Drug	Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; MCF7; HT_HG-U133A	SYNJ2 TMEM259 AIG1 SCAPER PML DEAF1 PMEL CD40 SMARCA2	1.11e-04	196	216	9	3435_UP
Drug	Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A	ACACB PLCL2 PML MXRA5 TRIM2 AFF3 TRIM3 CD22 FUT2	1.11e-04	196	216	9	2784_UP
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HG-U133A	ERCC2 MATN1 SYNPO STAT1 SYNJ2 PLCB1 NPAT FUT2 STX6	1.11e-04	196	216	9	203_DN
Drug	Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A	SPAG1 THNSL1 GIT2 PLCB1 TRIM2 CEP290 SMARCA2 FUT2 STX6	1.11e-04	196	216	9	7425_UP
Drug	Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A	ABCA1 ERCC4 SYNJ2 AIG1 FLNC TRIM2 XRCC2 ATF6 PCNX1	1.11e-04	196	216	9	3534_DN
Drug	Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; HL60; HT_HG-U133A	ERCC2 BCORL1 RNF40 PML NPR2 ZCWPW1 DEAF1 SUN1 AKAP9	1.11e-04	196	216	9	1338_UP
Drug	Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A	ERCC4 SYNJ2 SCAPER TNS2 XRCC2 TRIM3 ATF6 SETD2 AKAP9	1.11e-04	196	216	9	3255_DN
Drug	Benzamil hydrochloride [2898-76-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	PDE4D CEACAM5 SPTAN1 PLCL2 PML TRIM2 APOB FRY CD40	1.11e-04	196	216	9	3738_UP
Drug	Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A	RAB11B GCDH GIT2 CEMIP2 SYNJ2 ALDH5A1 DZANK1 SMARCA2 PCNX1	1.11e-04	196	216	9	2844_DN
Drug	6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A	CEACAM5 EVPL CDKAL1 UTRN TRIM3 SIGLEC7 CD22 SMARCA2 AKAP13	1.11e-04	196	216	9	4833_UP
Drug	Panthenol (D) [81-13-0]; Up 200; 19.4uM; PC3; HT_HG-U133A	ACACB SPTAN1 SYNJ2 SCAPER UTRN PML TRIM2 ARHGEF12 PCNX1	1.16e-04	197	216	9	1802_UP
Drug	Doxepin hydrochloride [1229-29-4]; Up 200; 12.6uM; HL60; HT_HG-U133A	PDE4D MATN1 GSDME STX5 PML NPR2 SIGLEC7 FUT2 EPAS1	1.16e-04	197	216	9	2384_UP
Drug	Ampicillin trihydrate [7177-48-2]; Up 200; 10uM; MCF7; HT_HG-U133A	ABCA1 GIT2 CDKAL1 SYNJ2 DYRK3 AKAP9 CD22 PCNX1 MARK2	1.16e-04	197	216	9	1530_UP
Drug	N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A	NES SPTAN1 GIT2 PRDM2 ANKS1A ZCWPW1 CDK5RAP2 MARK2 ZNF124	1.16e-04	197	216	9	5332_DN
Drug	Benzthiazide [91-33-8]; Down 200; 9.2uM; PC3; HT_HG-U133A	PDE4D ERCC4 SYNPO ITGA2B STAT1 KCNS3 UTRN PCNX1 AKAP13	1.16e-04	197	216	9	6607_DN
Drug	Dubinidine [22964-77-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A	KIF21B SPTAN1 GIT2 UTRN PML DYRK3 ZCWPW1 DZANK1 PCNX1	1.16e-04	197	216	9	6250_UP
Drug	Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; PC3; HT_HG-U133A	MAGI1 CEACAM5 MATN1 PRDM2 PML CCDC170 TRIM3 PAPOLG CD22	1.16e-04	197	216	9	3686_UP
Drug	Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A	GIT2 UTRN PML TRIM2 TRIM3 SMARCA2 PCNX1 ZNF749 MARK2	1.16e-04	197	216	9	3798_DN
Disease	brain measurement, neuroimaging measurement	KIF21B MAGI1 SLIT2 MIB1 TNRC6A NAV2 KCNS3 ABCG2 MAP3K7 ANKS1A FAT3 GBA2 HHIP NTAN1 SMARCA2 KIAA1755	1.94e-06	550	207	16	EFO_0004346, EFO_0004464
Disease	Intellectual Disability	RAB11B RAB11A ACTL6A NRXN2 SCAPER ALDH5A1 PUS7 DEAF1 TCF20 AFF3 CHD8 SIN3A SETD2 FRY	3.74e-06	447	207	14	C3714756
Disease	age at menarche	KCTD9 PDE4D GCDH CDKAL1 PRDM2 DST TNRC6A PLCB1 PLCL1 PML BRWD1 CCDC170 AFF3 DZANK1 SMARCA2 EPAS1	5.17e-06	594	207	16	EFO_0004703
Disease	neuroimaging measurement	KIF21B MAGI1 STAT1 SLIT2 TNRC6A NAV2 KCNS3 ABCG2 PLCL1 MAP3K7 ANKS1A FAT3 AFF3 ZDHHC5 ARHGEF12 ZNF106 HHIP BAZ1A SMARCA2 KIAA1755 STX6	2.27e-05	1069	207	21	EFO_0004346
Disease	Colorectal Carcinoma	ABCA1 ERCC2 ABCA13 EFEMP1 FEN1 ABCG2 TTLL10 FLNC APOB CUBN LIG1 HHIP SIGLEC7 AKAP9 ZNF540 ZMYM4	3.98e-05	702	207	16	C0009402
Disease	cortical thickness	MAGI1 STOX1 STAT1 SLIT2 UBN1 PMPCA TNRC6A NAV2 KCNS3 MAP3K7 ANKS1A NPR2 FAT3 ARHGEF12 ZNF106 HHIP MALRD1 BAZ1A KIAA1755 CDK5RAP2 STX6	4.07e-05	1113	207	21	EFO_0004840
Disease	pre-eclampsia (is_marker_for)	PML TIMP1 CD40 AKR1C3 EPAS1	5.48e-05	58	207	5	DOID:10591 (is_marker_for)
Disease	Adenoid Cystic Carcinoma	MAGI1 BCORL1 SETD2 SMARCA2 MARK2 ESPL1	7.64e-05	100	207	6	C0010606
Disease	Neoplasms, Hormone-Dependent	AKR1C1 AKR1C3	1.46e-04	3	207	2	C0027661
Disease	autosomal recessive limb-girdle muscular dystrophy type 2H (implicated_via_orthology)	TRIM2 TRIM3	1.46e-04	3	207	2	DOID:0110282 (implicated_via_orthology)
Disease	autosomal recessive limb-girdle muscular dystrophy (implicated_via_orthology)	TRIM2 TRIM3	1.46e-04	3	207	2	DOID:0110274 (implicated_via_orthology)
Disease	cholesteryl ester 18:3 measurement	FEN1 NAV2 APOB NTAN1	1.76e-04	40	207	4	EFO_0010346
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	KDM3A ERCC4 CEMIP2 SLIT2 NRXN2 TULP4 KCNC2 LRRTM4 PLCL2 TNRC6A MAP3K7 UTRN BRWD1 TCF20 AFF3 CD40	1.83e-04	801	207	16	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	cortical surface area measurement	MAGI1 ZC3H13 STOX1 STAT1 CDKAL1 SLIT2 PMPCA TNRC6A NAV2 KCNS3 PLCL1 MAP3K7 ANKS1A ITGA11 NPR2 TRIM2 FAT3 ARHGEF12 ZNF106 HHIP KIAA1755 ARHGAP28	2.09e-04	1345	207	22	EFO_0010736
Disease	response to antidepressant	ERCC4 SLC26A8 ABCG2 MUC19 XRCC2 ZNF248 CD22	2.56e-04	176	207	7	GO_0036276
Disease	ceramide measurement	ABCA1 PDE4D TTLL10 MAP3K7 ADGRA3 APOB GBA2 ZNF106	2.69e-04	235	207	8	EFO_0010222
Disease	von Willebrand's disease 1 (is_implicated_in)	ITGA2B VWF	2.91e-04	4	207	2	DOID:0060573 (is_implicated_in)
Disease	asthma	MAGI1 PDE4D ERCC4 CDHR3 HLA-DRB5 ITGAV TCHHL1 PLCL2 PLCL1 AFF3 ZKSCAN2 PMEL DZANK1 SMARCA2 CDK5RAP2	2.92e-04	751	207	15	MONDO_0004979
Disease	muscular dystrophy (implicated_via_orthology)	UTRN TRIM2 TRIM3	4.12e-04	21	207	3	DOID:9884 (implicated_via_orthology)
Disease	Profound Mental Retardation	SCAPER ALDH5A1 DEAF1 CHD8 SIN3A FRY	4.59e-04	139	207	6	C0020796
Disease	Mental Retardation, Psychosocial	SCAPER ALDH5A1 DEAF1 CHD8 SIN3A FRY	4.59e-04	139	207	6	C0025363
Disease	Mental deficiency	SCAPER ALDH5A1 DEAF1 CHD8 SIN3A FRY	4.59e-04	139	207	6	C0917816
Disease	Hermaphroditism	AKR1C1 AKR1C3	4.83e-04	5	207	2	C0019269
Disease	Ambiguous Genitalia	AKR1C1 AKR1C3	4.83e-04	5	207	2	C0266362
Disease	Pseudohermaphroditism	AKR1C1 AKR1C3	4.83e-04	5	207	2	C0033804
Disease	Intersex Conditions	AKR1C1 AKR1C3	4.83e-04	5	207	2	C2930618
Disease	Sex Differentiation Disorders	AKR1C1 AKR1C3	4.83e-04	5	207	2	C2930619
Disease	asthma exacerbation measurement	CDHR3 PTPRM TCF20 MALRD1 FUT2	5.10e-04	93	207	5	EFO_0007614
Disease	red blood cell density measurement	SRRM1 RAB11B RAB11A GCDH CDKAL1 TFCP2L1 DST PLCL2 ULK4 TNS3 ZYG11A AFF3 ZNF106 TIMP1 BAZ1A AKAP13	5.15e-04	880	207	16	EFO_0007978
Disease	Malignant neoplasm of breast	GABRP KDM3A SPTAN1 BCORL1 FSCB STAT1 EFEMP1 STX5 SYNJ2 PLCB1 NLRC5 ABCG2 VWF XRCC2 CUBN SETD2 AKAP9 CD40	6.05e-04	1074	207	18	C0006142
Disease	urate measurement	ABCA1 CDKAL1 TFCP2L1 NRXN2 SCAPER KCNS3 ABCG2 HERC6 ZKSCAN2 SIN3A VARS2 CUBN MALRD1 AKAP13 MBD5 EPAS1	6.18e-04	895	207	16	EFO_0004531
Disease	Dwarfism	ERCC4 PUS7 SIN3A	6.98e-04	25	207	3	C0013336
Disease	coronary artery disease (is_implicated_in)	ABCA1 ERCC2 MMP12 APOB CUBN	7.10e-04	100	207	5	DOID:3393 (is_implicated_in)
Disease	xeroderma pigmentosum (is_implicated_in)	ERCC2 ERCC4	7.21e-04	6	207	2	DOID:0050427 (is_implicated_in)
Disease	xeroderma pigmentosum (implicated_via_orthology)	ERCC2 ERCC4	7.21e-04	6	207	2	DOID:0050427 (implicated_via_orthology)
Disease	familial combined hyperlipidemia (is_marker_for)	VWF APOB	7.21e-04	6	207	2	DOID:13809 (is_marker_for)
Disease	Cockayne syndrome (implicated_via_orthology)	ERCC2 ERCC4	7.21e-04	6	207	2	DOID:2962 (implicated_via_orthology)
Disease	DNA methylation	ABCA1 ERCC4 ABCA13 MATN1 KCNC2 PTPRM LRRTM4 PLCB1 MMP12 TNS3 FRY SMARCA2 ZNF124	7.92e-04	656	207	13	GO_0006306
Disease	Colorectal Neoplasms	ABCA1 ERCC2 ABCA13 EFEMP1 FEN1 ABCG2 FLNC HHIP	7.97e-04	277	207	8	C0009404
Disease	free cholesterol in HDL measurement	ABCA1 NLRC5 APOB NTAN1	8.98e-04	61	207	4	EFO_0022264
Disease	mean platelet volume	SRRM1 BCORL1 ITGA2B UBN1 TNRC6A PLCB1 ANKS1A VWF POLA1 AFF3 SIN3A XRCC2 RSBN1 SETD2 FRY TIMP1 ESPL1	9.11e-04	1020	207	17	EFO_0004584
Disease	phosphatidylcholine measurement	ABCA1 NRXN2 FEN1 PLCB1 APOB OVCH1 NTAN1 MALRD1	9.36e-04	284	207	8	EFO_0010226
Disease	B-cell lymphoma (is_implicated_in)	ABCG2 CD40	1.00e-03	7	207	2	DOID:707 (is_implicated_in)
Disease	permanent dental caries	MAP3K7 PAPOLG	1.00e-03	7	207	2	EFO_0600096
Disease	Disorders of Sex Development	AKR1C1 AKR1C3	1.00e-03	7	207	2	C0036875
Disease	monocyte count	MATN1 HLA-DRB5 RAB11A ARHGAP30 TLR8 CDKAL1 PLCL2 PLCB1 NLRC5 DTHD1 TNS3 NPAT ZYG11A ARHGEF12 RSBN1 ATF6 SETD2 BAZ1A AKAP13 MBD5	1.05e-03	1320	207	20	EFO_0005091
Disease	FEV/FEC ratio	SPEG ITGAV CEMIP2 EFEMP1 DST PTPRM SCAPER NAV2 ULK4 KCNS3 PLCL1 DENND5A DTHD1 PML AFF3 ZKSCAN2 ZNF106 HHIP FUT2	1.10e-03	1228	207	19	EFO_0004713
Disease	cortical surface area measurement, neuroimaging measurement	MAGI1 TNRC6A NAV2 MAP3K7 FAT3 HHIP KIAA1755	1.16e-03	227	207	7	EFO_0004346, EFO_0010736
Disease	total lipids in very large HDL measurement	ABCA1 NLRC5 APOB NTAN1	1.21e-03	66	207	4	EFO_0022312
Disease	eicosapentaenoic acid measurement	FEN1 NAV2 PAPOLG	1.32e-03	31	207	3	EFO_0007760
Disease	cholesteryl esters to total lipids in large LDL percentage	ABCA1 NLRC5 APOB	1.32e-03	31	207	3	EFO_0022249
Disease	lifestyle measurement, alcohol consumption measurement	CEMIP2 UTRN VWF TTC27 CDH17	1.33e-03	115	207	5	EFO_0007878, EFO_0010724
Disease	electrocardiography	SPEG NAV2 PLCL1 CCDC170 TRIM2 ZDHHC5 ZNFX1 KIAA1755 PCNX1 EPAS1 CDH17	1.38e-03	530	207	11	EFO_0004327
Disease	cholesterol in very large HDL measurement	ABCA1 NLRC5 APOB NTAN1	1.42e-03	69	207	4	EFO_0022229
Disease	Rheumatoid Arthritis	STAT1 GSDME ABCG2 MMP12 AFF3 CD40	1.48e-03	174	207	6	C0003873
Disease	fatty liver disease (biomarker_via_orthology)	ABCA1 HSPA5 APOB	1.59e-03	33	207	3	DOID:9452 (biomarker_via_orthology)
Disease	Xeroderma pigmentosum	ERCC2 ERCC4	1.71e-03	9	207	2	cv:C0043346
Disease	bringing up phlegm, sputum or mucus on most days, self-reported	HLA-DRB5 FUT2	1.71e-03	9	207	2	EFO_0009824
Disease	urticaria, response to non-steroidal anti-inflammatory, angioedema	ABI3BP EPAS1	1.71e-03	9	207	2	EFO_0005531, EFO_0005532, EFO_0005533
Disease	total lipids in large HDL	ABCA1 APOB NTAN1 CD40	1.84e-03	74	207	4	EFO_0022189
Disease	cerebrospinal fluid clusterin measurement	ABCA13 ZC3H13 DST	1.89e-03	35	207	3	EFO_0007657
Disease	free cholesterol in small HDL measurement	ABCA1 HLA-DRB5 NLRC5	1.89e-03	35	207	3	EFO_0022270
Disease	alcohol dependence	CENPE ULK4 ANKS1A ABI3BP PCNX1 ZNF124	1.91e-03	183	207	6	MONDO_0007079
Disease	polymeric immunoglobulin receptor measurement	IL20 FUT2	2.12e-03	10	207	2	EFO_0008267
Disease	cystic kidney disease (implicated_via_orthology)	SLIT2 CEP290	2.12e-03	10	207	2	DOID:2975 (implicated_via_orthology)
Disease	hematocrit	SRRM1 BCORL1 GCDH SYNPO CDKAL1 TFCP2L1 PLCL2 PLCB1 ULK4 ZYG11A AFF3 APOB DZANK1 TIMP1 FUT2 EPAS1	2.17e-03	1011	207	16	EFO_0004348
Disease	sleep latency	ERCC4 MALRD1 EPAS1	2.22e-03	37	207	3	EFO_0005280
Disease	Graves' disease (is_implicated_in)	C4A C4B CD40	2.58e-03	39	207	3	DOID:12361 (is_implicated_in)
Disease	pars orbitalis volume measurement	CFAP95 SLIT2	2.58e-03	11	207	2	EFO_0010320
Disease	Basal cell carcinoma	ERCC2 ERCC4	2.58e-03	11	207	2	C0007117
Disease	femoral neck bone mineral density	PDE4D CDKAL1 CCDC170 USF3 MALRD1 ESPL1	2.68e-03	196	207	6	EFO_0007785
Disease	platelet component distribution width	SRRM1 ITGA2B SYNJ2 PLCB1 ANKS1A BRWD1 ZCWPW1 VWF SIN3A CUBN SETD2 AKAP13 EPAS1	2.74e-03	755	207	13	EFO_0007984
Disease	cognitive function measurement	MAGI1 CFAP95 PDE4D ERCC4 CCDC66 TULP4 KCNC2 PLCL2 TNRC6A PLCB1 PLCL1 MAP3K7 ADGRA3 PUS7 TCF20 GOSR1 AFF3 CEP192 CD40 CDH17	2.78e-03	1434	207	20	EFO_0008354
Disease	valine measurement	ACACB ABCG2 MALRD1	2.78e-03	40	207	3	EFO_0009792
Disease	gestational age	SLIT2 UTRN VARS2 MALRD1 PCNX1	2.95e-03	138	207	5	EFO_0005112
Disease	cancer (implicated_via_orthology)	ERCC4 DST FEN1 SIN3A LIG1 SMARCA2 EPAS1	2.95e-03	268	207	7	DOID:162 (implicated_via_orthology)
Disease	metabolic syndrome	ABCA1 CDKAL1 TNRC6A APOB NTAN1 FUT2	2.97e-03	200	207	6	EFO_0000195
Disease	rac GTPase-activating protein 1 measurement	HLA-DRB5 C4B	3.09e-03	12	207	2	EFO_0801985
Disease	diffuse large B-cell lymphoma (is_implicated_in)	CD22 CD40	3.09e-03	12	207	2	DOID:0050745 (is_implicated_in)
Disease	abdominal aortic aneurysm (is_implicated_in)	ITGAV MMP12	3.09e-03	12	207	2	DOID:7693 (is_implicated_in)
Disease	ADHD symptom measurement	LRRTM4 ARHGEF12	3.09e-03	12	207	2	EFO_0007860
Disease	complex trait	ABCA1 TNRC6A NLRC5 APOB HHIP KIAA1755 FUT2	3.14e-03	271	207	7	EFO_0010578
Disease	Bladder Neoplasm	ERCC2 ERCC4 PRDM2 LIG1 ESPL1	3.14e-03	140	207	5	C0005695
Disease	amino acid measurement	PDE4D SETX ACACB SYNPO SLIT2 ULK4 ABCG2 MAP3K7 ITGA11 VWF LIG1 EPAS1	3.18e-03	678	207	12	EFO_0005134
Disease	high grade glioma (is_marker_for)	EFEMP1 HSPA5 BRD7	3.19e-03	42	207	3	DOID:3070 (is_marker_for)
Disease	primary immunodeficiency disease (is_implicated_in)	TLR8 ZNFX1 LIG1	3.19e-03	42	207	3	DOID:612 (is_implicated_in)
Disease	schizophrenia, intelligence, self reported educational attainment	ERCC4 PLCL2 PLCL1 FAT3 AFF3 COA8 SMARCA2 PCNX1	3.21e-03	346	207	8	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	Malignant neoplasm of urinary bladder	ERCC2 ERCC4 PRDM2 LIG1 ESPL1	3.24e-03	141	207	5	C0005684
Disease	intraocular pressure measurement	CFAP95 ABCA1 HLA-DRB5 EFEMP1 SYNJ2 MXRA5 AFF3 ARHGEF12 ZNF106 AKAP13	3.34e-03	509	207	10	EFO_0004695
Disease	Hyperlipoproteinemia Type IIb	ABCA1 APOB	3.63e-03	13	207	2	C1704417
Disease	retinal vasculature measurement	PDE4D ERCC4 HLA-DRB5 PLCB1 PLCL1 TTLL10 CCDC170 AFF3 ZNF106 FRY	3.73e-03	517	207	10	EFO_0010554
Disease	Schizophrenia	MAGI1 ABCA1 PDE4D ABCA13 ZDHHC8 SLC26A8 NRXN2 PLCL2 PLCB1 ULK4 KCNS3 PML SMARCA2 MARK2	3.98e-03	883	207	14	C0036341
Disease	uric acid measurement	ABCA1 NRXN2 KCNS3 ABCG2 SESTD1 FAT3 ZDHHC5 TTC27 CUBN AKAP13 EPAS1	4.06e-03	610	207	11	EFO_0004761
Disease	neutrophil count	MAGI1 NES HLA-DRB5 BCORL1 RAB11A CDKAL1 PMPCA TNRC6A PLCB1 NLRC5 PLCL1 DTHD1 TNS3 ARHGEF12 RSBN1 ATF6 SETD2 AKAP13 ZMYM4	4.11e-03	1382	207	19	EFO_0004833
Disease	end stage renal disease (is_marker_for)	VWF IL20 CD40	4.14e-03	46	207	3	DOID:783 (is_marker_for)
Disease	thoracic aortic aneurysm (is_marker_for)	MMP12 TIMP1	4.22e-03	14	207	2	DOID:14004 (is_marker_for)
Disease	cerebellum cortex volume change measurement	PTPRM EPAS1	4.22e-03	14	207	2	EFO_0021497
Disease	Asbestosis	HSPA5 ATF6	4.22e-03	14	207	2	C0003949
Disease	Pulmonary Fibrosis - from Asbestos Exposure	HSPA5 ATF6	4.22e-03	14	207	2	C2930617
Disease	systemic lupus erythematosus	CYP4F8 HLA-DRB5 STAT1 C4B PLCL1 PUS7 ANKS1A DEAF1 AFF3 PAPOLG RSBN1 CD40 C1QTNF12	4.41e-03	799	207	13	MONDO_0007915

Protein segments in the cluster

Peptide	Gene	Start	Entry
KGDELSNRIQNTLGN	AFF3	61	P51826
GQKNSTLIFTRENTI	C21orf62	26	Q9NYP8
EKLEQSEAQLGRGSF	COPS5	271	Q92905
EEIRENLSLKNGSGF	EPAS1	141	Q99814
VQAEIGKLRAQASGS	RNF40	511	O75150
AQQTELSRISGGKEN	AKAP9	1456	Q99996
SGRDGNITGIQQFSK	CHD8	1286	Q9HCK8
DLSSLLTRGSGNQEQ	AIG1	61	Q9NVV5
FRGLESQTKLVNGQS	C4B	296	P0C0L5
GRLQSGVNTLQGFKE	BRD7	376	Q9NPI1
KTSLNLRTSNVGNFD	BPIFB4	546	P59827
DAGLAKSIGVSNFNR	AKR1C3	156	P42330
GNSTNLADDGKRRTV	ADGRA3	651	Q8IWK6
FVSNLATGRNNSIVK	CEACAM5	656	P06731
SQSSFGTLRKQEVDL	GSDME	111	O60443
SELRNKGFQRGASQE	GSG1	321	Q2KHT4
GDTTVTRGDAFLNKN	ABCA1	1961	O95477
AGGNTLIQSFTDRLN	ACTL6A	351	O96019
LKNDSTGIQNRAGVL	ABCG2	416	Q9UNQ0
ALDSRQGVGEKNTFI	BCORL1	161	Q5H9F3
NVLQGGESTKERFEN	AKAP13	496	Q12802
FDNKGSSLQNREGEL	ABCA13	3821	Q86UQ4
RQQGSSLSGSKDNVE	GIT2	356	Q14161
QKAQSIGIFSDGDSR	ECT2L	336	Q008S8
GLESNSRVFTLQVQG	C1QTNF12	251	Q5T7M4
IRRFNKEGGTSILDN	NPR2	786	P20594
SSIGEGIDFSQERQK	ANKS1A	676	Q92625
GIDFSQERQKISGLR	ANKS1A	681	Q92625
KTRILQGALEQGSNS	ATF6	506	P18850
GKLSSSFSSRGQQQE	BAZ1A	1276	Q9NRL2
QDSAKLRQSGLANEG	ARHGEF12	641	Q9NZN5
KQLERQGSEFVQGST	CDK5RAP2	1421	Q96SN8
TSSGENLFRINGQRI	NWD2	1386	Q9ULI1
GVGKSNLLSRFTRNE	RAB11A	21	P62491
GVGKSNLLSRFTRNE	RAB11B	21	Q15907
ENDTGFQAQDISGRK	RGPD5	941	Q99666
SSTSLEKNNVLFGER	MMP12	21	P39900
RGNEGTLESINEKTF	KIN	351	O60870
QNGGLRSEKSIASLQ	NPAT	1191	Q14207
SGTVQELNFRSSKNV	ACACB	666	O00763
SQFTDLNGSKRFGIN	CFAP95	186	Q5VTT2
EKGGQQLAASERLSF	OBSL1	46	O75147
RGEEGLFSKDQNTVT	OVOS1	1036	Q6IE37
AAQRSQGLASGEKVA	DDI1	121	Q8WTU0
NETGNQKDGNSFLSI	DNAJC14	111	Q6Y2X3
QEANLRGSNVKGAIF	KCTD9	361	Q7L273
EKSRSLNNIAGLAGN	KCNC2	596	Q96PR1
SGSGVNNRRTELFLK	GOSR1	151	O95249
AQKVGIVFTDGRSQD	MATN1	376	P21941
SKGEREREINSTNFG	MAGI1	816	Q96QZ7
FRNSQEEKAGVVSTG	HLA-DRB5	161	Q30154
GGSQGLSLRFNSIQK	LRRTM4	61	Q86VH4
RGAVALGTNSLKQQE	NCKAP5L	726	Q9HCH0
EEIGQKNISRTSFTQ	FSCB	206	Q5H9T9
RANVITSTQAKGLGN	GPR155	61	Q7Z3F1
ELSKQAAQLGATARG	KIAA1755	901	Q5JYT7
LQSDSKRLESGVQFQ	DST	411	Q03001
RGDKTNQGISELNAS	PHKA1	186	P46020
SQKGGLDRFQAAVQT	PHKA1	681	P46020
NTGERFKESIQINSG	KIF27	256	Q86VH2
SGEFQLAGDLKINTS	PCNX1	336	Q96RV3
IESGGDFNIEIKRNN	MUC19	511	Q7Z5P9
GRQGQTEKFQFELTL	PDE4D	726	Q08499
TSTQRLLNAQKAFTG	EVPL	1891	Q92817
KLTRLLQDSLGGNSQ	KIF21B	326	O75037
EGGLVNKANRFTVET	FLNC	1361	Q14315
LTQDGKVFTFGDNRS	HERC6	251	Q8IVU3
QAKQQSESGRLSLGA	MAP3K7	356	O43318
VDFQRDGRKGSISVN	NRXN2	591	Q9P2S2
GGKSLARALQQNTSL	NOD1	856	Q9Y239
GQFLKFTQREGDRES	NES	1601	P48681
DDLRQTEGFKNVSLG	DPP3	396	Q9NY33
GRGNDQVAISSKFET	ERCC2	496	P18074
VGGFKQSVDQSTLLR	KCNS3	21	Q9BQ31
GDRIFSLEGTNKNET	ITGA11	346	Q9UKX5
TGNFVIGQILSDQSR	POLA1	1091	P09884
DVSISDLFNTRVNKG	NLRC5	206	Q86WI3
LTKANIVRSGDAAQG	MIB1	311	Q86YT6
FGDGKTRSNIISFQT	PTPRQ	971	Q9UMZ3
TIFNSQAAIKIGGRD	NRXN2	241	P58401
SVFTRTSLDGNLQKQ	MALRD1	566	Q5VYJ5
KQSLSDVNRSSGGLQ	PAPOLG	506	Q9BWT3
GAGSKTLQQNAESRF	BAG2	196	O95816
TERGNLVFLTGSAQN	CUBN	46	O60494
ITASTNNEGNLKVRF	APOB	3046	P04114
RVNFGTLLSSQKEAE	ESPL1	6	Q14674
SRQGSTQGRLDDFFK	FEN1	331	P39748
NSGFLRNLLNSSTGK	KDM3A	881	Q9Y4C1
RNLLNSSTGKTENGL	KDM3A	886	Q9Y4C1
SAAQTEKGGRTQSQL	GCDH	26	Q92947
IQDKFSSILSRGQEA	GBA2	711	Q9HCG7
RQSEGSNVVFKGIDL	CEP290	751	O15078
GRTALQIGDSLNTEK	DEAF1	131	O75398
VSGLTKDFRNGLGNQ	CDKAL1	511	Q5VV42
RDSGGLKASTELQVN	CDHR3	211	Q6ZTQ4
LENGQIKSFTFDGRT	FRMPD3	186	Q5JV73
EEAQKFLRGLQVNGS	FUT2	176	Q10981
RASGDFQTTKLNGFE	ITGAV	351	P06756
RTLTSQGVDDFLQAK	CYP4F8	276	P98187
GRTTIANLKSGNNLL	TMEM63B	191	Q5T3F8
NSGIKNGNFALRITA	FAT3	641	Q8TDW7
QGNRSLSLTENGKEA	CCDC66	166	A2RUB6
VFGDNKDGSRNITLR	CEMIP2	161	Q9UHN6
SELVSDKRNGNIAGS	DENND5A	441	Q6IQ26
KENNTSLNGRVLGQE	DTHD1	66	Q6ZMT9
SLNGRVLGQEESQNK	DTHD1	71	Q6ZMT9
SLETGEILKARAGNN	BRWD1	1611	Q9NSI6
RASLGQASIQNGKDS	MARK2	491	Q7KZI7
NEENKGFLRNVVSGE	TMEM259	276	Q4ZIN3
RQSRGFGELLSTAKQ	MBD5	1296	Q9P267
FQNRGKGTLSSIIQN	CEP192	1096	Q8TEP8
FSEIRGSVQAKDGNI	IL20	46	Q9NYY1
VSGGVLRDNLNFEKQ	CCDC170	416	Q8IYT3
DNLRGIGSKFVSSSQ	FRY	2731	Q5TBA9
AKFGQGLEDQLAQTR	DZANK1	731	Q9NVP4
SQGSQNKLLLVSFDG	ENPP7	26	Q6UWV6
RQATKDAGTIAGLNV	HSPA5	181	P11021
QINNKTGAISLTREG	CDH17	181	Q12864
GGEVKIFSRNQEDNT	LIG1	581	P18858
ILGRNTNKQVFEGLT	SCAPER	1036	Q9BY12
SKLTRILQNSLGGNA	CENPE	286	Q02224
EFGNRKSNTIQSDGI	DYRK3	91	O43781
NGRLLGKESQLNFDS	CD22	546	P20273
FRGLESQTKLVNGQS	C4A	296	P0C0L4
IQGSQFNVEVGRSDK	GABRP	21	O00591
QSQGSLEGASRDVKN	KRBA2	356	Q6ZNG9
RKSGQLNLSGRNLSE	LRRC40	36	Q9H9A6
NGVVVLDNSGKNAFR	PRDM2	1381	Q13029
DLSNQSGRVSKLGNE	PTPRM	531	P28827
NLLRSKDIEASGFNG	ARHGAP30	176	Q7Z6I6
KGVAFTNTSDLGQRI	P2RX5	71	Q93086
NTINTFRIKSGNENG	EFEMP1	421	Q12805
GQINSTSGLNKESFR	RSBN1	296	Q5VWQ0
GEAGTQRQQKLSSLQ	VARS2	1021	Q5ST30
TLDNGLRVASQNKFG	PMPCA	71	Q10713
SFAALNRTGDGIVQK	UTRN	2031	P46939
NRTGDGIVQKLSQAD	UTRN	2036	P46939
KNLRVGNGFEEGTTQ	ALDH5A1	366	P51649
FSSVTKRGLNVDQLN	STAT1	506	P42224
GNSSGRQLSEVFIQL	SMARCA2	1416	P51531
TIERRGSKSSQQEFQ	SPATA5L1	601	Q9BVQ7
SRNKFIGFTLGQDTD	STRIP2	436	Q9ULQ0
DGSRFDLTVRTQKQG	SYNJ2	136	O15056
VNEFTLESHGQRGQK	SYNPO	181	Q8N3V7
ARTIIQDKSGGRQQF	SLC26A8	416	Q96RN1
ALSSVQEVNGSQRGK	OVCH1	316	Q7RTY7
NQSVREFLDGTRKTN	PML	171	P29590
TGKNTDIFRSNGISD	PLCL2	196	Q9UPR0
LRKSGSVENGFDTQI	NAV2	76	Q8IVL1
TKGQDGLQNDFLSIS	PUS7	41	Q96PZ0
RNEGQSDTNKRDLVG	SETX	1181	Q7Z333
KDANTIRGSASQGNL	SIGLEC7	396	Q9Y286
EEQAKFRLDNTLGGT	SIN3A	646	Q96ST3
ERKNRQALLGDSGSQ	STX6	116	O43752
KASGAGSEFQDQTRI	NOM1	531	Q5C9Z4
AQAGGTDLLKQTQER	SEC31B	596	Q9NQW1
KTRLQSQIGGEFQSF	SLC25A52	236	Q3SY17
GNTGENFRKNLTDVI	TDRD7	871	Q8NHU6
ETRNVGSQTLQTFKA	ITGA2B	106	P08514
GSQTLQTFKARQGLG	ITGA2B	111	P08514
VGGFSDDRQLSQKLT	NTAN1	126	Q96AB6
FKVSAQGITLTDNQR	TNS3	1351	Q68CZ2
LQQKRDGSGDSNLSV	TFCP2L1	386	Q9NZI6
SVSVSQLRALDGGNK	PMEL	216	P40967
GLGRLENKIFSVTNN	HHIP	86	Q96QV1
QGDGLRELNKQESAS	SPICE1	696	Q8N0Z3
GIGDSIRASQALQQK	SESTD1	301	Q86VW0
AQLQDFVRAKGSQSG	STX5	151	Q13190
DAGLAKSIGVSNFNR	AKR1C1	156	Q04828
GLRTESGQKATLNAE	COA8	136	Q96IL0
TDQLLQGSEKGFQSR	TIMP1	171	P01033
GGRVTQESAKNFQIE	TULP4	1486	Q9NRJ4
IRLGKNTETFRNNGL	PLCL1	166	Q15111
SNGLNITDGAFLNLK	TLR8	111	Q9NR97
SEFEGQQGLKERSIS	ZNF540	126	Q8NDQ6
HSQIRDQQKGEISGF	ZCWPW1	236	Q9H0M4
QGGKDFTASSDLLQQ	ZNF749	156	O43361
VAIGQFKDRITGSND	VSIG1	81	Q86XK7
EELSGTRHFKGQAQN	SEMA4G	41	Q9NTN9
SIIGDFQNGKRVSLS	VWF	71	P04275
ENRGLQKSSSFSQGE	SPEG	2121	Q15772
RTQSLGSNNSVILDG	STOX1	941	Q6ZVD7
NVQKTRFGLTEAGDL	ARHGAP28	321	Q9P2N2
KLGESQTLQQFSRDV	SPTAN1	1546	Q13813
QINLTGFLNGKNARE	SRRM1	86	Q8IYB3
AGLKSQGNELFRSGQ	SPAG1	446	Q07617
DTGSAVLNGFSRLNK	THNSL1	381	Q8IYQ7
GVSDFQKAQIIGSQR	THNSL1	411	Q8IYQ7
DLNGNNITRITKTDF	SLIT2	61	O94813
EKVNSGSLNNRFGSI	USF3	2141	Q68DE3
NGRLTAQFGITRKDS	TRAV35	76	P0DPF4
NELASRGLLNKSIGS	TCF20	796	Q9UGU0
NNSLARKGQISVDGF	PLCB1	281	Q9NQ66
GEGLSDKNQVLSLSR	SETD2	1726	Q9BYW2
NGGESVNLQESTLRK	XRCC2	161	O43543
RSNQEGKVGFLQISN	ZNFX1	1201	Q9P2E3
FRNLASIGNKGEDQS	ZNF124	46	Q15973
NTSTQERVELGKTFN	ZNF717	121	Q9BY31
TTNEQVTGKFRGGVN	ZDHHC5	216	Q9C0B5
SEGIGLRESFQQKSR	ZNF445	346	P59923
EGESRQKFFTQDING	UBN1	376	Q9NPG3
AVFTQKSQLDGSQRV	ZNF484	286	Q5JVG2
DFRKENVGNVVSLGS	ZKSCAN2	256	Q63HK3
EAAGFQESRGTVKLQ	TMEM204	81	Q9BSN7
TTNEQVTGKFRGGVN	ZDHHC8	216	Q9ULC8
QGGSLEQLLQRFSSQ	SUN1	526	O94901
ESLRATEKAFGQNSG	ERCC4	311	Q92889
KIRDQFGEQEGNLAT	TCHHL1	246	Q5QJ38
RNKGEFTNLQGVAAS	TRIM2	481	Q9C040
SFLDGRTGQQLTSDQ	ABI3BP	1011	Q7Z7G0
NLENGSARKQGAESV	SLC5A12	571	Q1EHB4
SARKQGAESVLQNGL	SLC5A12	576	Q1EHB4
DLTGALGKRTRFQEN	TTC27	266	Q6P3X3
GSISTLKFQRTQQGD	TRBV7-1	91	A0A0A6YYK4
ASNQGKGIFLLRNQE	TTLL10	316	Q6ZVT0
GKLTDRTASIFRGNQ	ZYG11A	86	Q6WRX3
FGSQKQSGDNLNDTL	ZNF106	521	Q9H2Y7
DGLRNSTGLGSQNKF	TNRC6A	281	Q8NDV7
SSGLQSAIDQIRAGK	ULK1	911	O75385
FKVSAQGITLTDNQR	TNS2	1316	Q63HR2
VSVENGDRGSKTFNL	ZNF248	111	Q8NDW4
GSELGNSFASNIRIK	ZMYM4	236	Q5VZL5
NLGLRVQQKGTSETD	CD40	86	P25942
LGSVQGFEETNKSER	ZC3H13	1421	Q5T200
REKGEFTNLQGVSAA	TRIM3	481	O75382
VRLALQAQKSGSGED	ULK4	1126	Q96C45
SQTKEVTLEAFRGQG	GARIN5B	626	Q8N5Q1
SQKAGGFRNIAIQTS	INSYN2B	86	A6NMK8
QGSSLAQNRGKLEAQ	LRRCC1	776	Q9C099
GTLLIQKAQRSDSGN	MXRA5	2401	Q9NR99